Medicine Study Notes

A focused gallery for medical notes, diagrams, handwritten study images, and clinical learning material.

Anesthesia Calculators

Search calculators by name, keyword, formula, or reference. Each calculator opens separately and has its own inputs, formula, meta title, meta description, and references.

For trained clinicians only. Verify all outputs with institutional protocols, patient condition, drug labels, and senior anesthesiologist judgement.

Search calculators

Calculator List

Tap any calculator below to open it.

CAL

No calculator found. Try a different keyword.

Intra-op Fluid Management

Fluid plan and maximum allowable blood loss calculator.

Weight kg

NPO hours

NPO fluid given ml

Surgical stress

EBV factor

Initial Hb

Target Hb

Max Allowable Blood Loss

0 ml

Hour 1

Hour 2

Hour 3

Formula and calculation method

Maintenance fluid: 4-2-1 rule: first 10 kg x 4 ml/kg/hr, next 10 kg x 2 ml/kg/hr, remaining weight x 1 ml/kg/hr.

NPO deficit: maintenance rate x NPO hours minus fluid already given.

Intra-op plan: Hour 1 = half deficit + stress fluid, Hour 2 = quarter deficit + stress fluid, Hour 3 = stress fluid.

MABL: EBV x weight x (Initial Hb - Target Hb) / Initial Hb.

Formula: MABL = EBV x weight x (Hb initial - Hb target) / Hb initial.

Airway Calculator

Estimated ETT size, ETT depth, LMA and i-gel size.

Age years

Weight kg

Sex

Airway Estimate

ETT Size

ETT Depth

i-gel

LMA

Type

Check

Clinical

Formula and calculation method

Pediatric ETT: cuffed ETT ID = age / 4 + 3.5 mm. Adult estimate: male 8.0 mm, female 7.5 mm.

ETT depth: pediatric oral depth = age / 2 + 12 cm. Adult estimate: male 23 cm, female 21 cm.

i-gel and LMA: selected by weight bands. Always confirm with leak, ventilation, capnography and clinical fit.

Formula: Pediatric cuffed ETT ID = age / 4 + 3.5; pediatric oral depth = age / 2 + 12.

Infusion Rate Calculator

Calculate ml/hr from dose, weight and drug concentration.

Patient weight

Drug concentration

Required dose

Infusion Rate

0.00 ml/hr

Dose/hr

Conc/ml

Weight

0 kg

Formula and calculation method

Step 1: Weight is converted to kg if entered in pounds.

Step 2: Concentration is converted to mcg/ml, mg/ml or units/ml depending on selected dose type.

Step 3: Dose is converted to dose per hour. Weight-based doses are multiplied by patient weight.

Formula: ml/hr = total required dose per hour / concentration per ml.

Formula: infusion rate = dose per hour / concentration per ml.

Anesthesia Drug Dose

Common weight-based anesthesia drug dose list.

Weight kg

Formula and calculation method

Each dose is calculated as: weight x dose factor.

These are common reference ranges or typical doses, not a prescription. Adjust for age, ASA status, comorbidities, hemodynamics, renal/hepatic disease, pregnancy, frailty and institutional policy.

Formula: drug dose = patient weight in kg x selected drug dose in mg/kg or mcg/kg.

LAST Toxicity Limits

Local anesthetic maximum dose and maximum volume estimation.

Weight kg

Risk reduction

Formula and calculation method

Maximum dose: weight x maximum recommended mg/kg dose x risk factor.

Maximum volume: maximum mg / drug concentration in mg/ml.

Use the lowest effective dose. Toxicity may still occur below calculated maximums, especially after intravascular injection or in high-risk patients.

Formula: maximum dose = weight x mg/kg x risk factor; maximum volume = maximum mg / concentration mg/ml.

ASA Physical Status

Preoperative physical status classification.

ASA

ASA class

Emergency procedure

ASA Classification

ASA I

Normal healthy patient.

Formula and calculation method

ASA Physical Status is a categorical classification based on systemic disease burden. It is not a numeric mortality prediction model.

Method: Select ASA I-VI; add E when the procedure is emergent.

Aldrete Score

PACU recovery score for discharge readiness.

PACU

Activity

Respiration

Circulation

Consciousness

Oxygen saturation

Modified Aldrete Score

10 / 10

Usually acceptable for PACU discharge if local criteria are also met.

Formula and calculation method

Five domains are scored from 0 to 2: activity, respiration, circulation, consciousness and oxygen saturation.

Formula: Aldrete score = sum of five domain scores. Maximum = 10.

Apfel PONV Score

Postoperative nausea and vomiting risk prediction.

PONV

Female sex

Nonsmoker

History of PONV/motion sickness

Postoperative opioids

PONV Risk

0 points

Approximate risk: 10%.

Formula and calculation method

One point is assigned for each predictor: female sex, nonsmoker, history of PONV/motion sickness, and planned postoperative opioids.

Formula: Apfel score = number of positive predictors. Approximate risks: 0=10%, 1=20%, 2=40%, 3=60%, 4=80%.

STOP-BANG Score

Obstructive sleep apnea screening tool.

OSA

Snoring

Tired during daytime

Observed apnea

High blood pressure

BMI > 35

Age > 50

Neck circumference > 40 cm

Male sex

STOP-BANG Score

0 / 8

Low risk of OSA.

Formula and calculation method

Each positive STOP-BANG item scores 1 point.

Formula: STOP-BANG score = sum of 8 yes/no items. 0-2 low risk, 3-4 intermediate risk, 5-8 high risk.

Modified Mallampati Classification

Airway view classification.

Airway view

Mallampati Class

Class I

Usually easier laryngoscopic view, but not definitive alone.

Formula and calculation method

This is an anatomical classification based on visible oropharyngeal structures with mouth open and tongue protruded.

Method: Assign Class I-IV by visible structures; higher class suggests increased difficulty but must be combined with other airway assessments.

Maintenance Fluid Calculator

4-2-1 hourly and daily maintenance fluid.

Weight kg

Maintenance Rate

110 ml/hr

Daily

2640 ml/day

First 10 kg

Extra

Formula and calculation method

Uses the 4-2-1 rule for hourly maintenance fluid requirement.

Formula: 4 ml/kg/hr for first 10 kg + 2 ml/kg/hr for next 10 kg + 1 ml/kg/hr for each kg above 20 kg.

IV Drip Rate Calculator

Manual drip rate in drops per minute.

GTT

Volume ml

Time minutes

Drop factor gtt/ml

Drip Rate

42 gtt/min

Formula and calculation method

Manual drip rate depends on total volume, infusion time and drop factor of the IV set.

Formula: gtt/min = volume ml x drop factor gtt/ml / time minutes.

Tidal Volume / PBW Calculator

Predicted body weight and lung protective tidal volume.

Sex

Height cm

Predicted Body Weight

66.0 kg

6 ml/kg

396 ml

7 ml/kg

462 ml

8 ml/kg

528 ml

Formula and calculation method

Predicted body weight is calculated from sex and height, then tidal volume targets are calculated in ml/kg PBW.

Formula: male PBW = 50 + 0.91 x (height cm - 152.4); female PBW = 45.5 + 0.91 x (height cm - 152.4).

RASS Sedation Scale

Richmond Agitation-Sedation Scale.

RASS

Clinical state

RASS Score

Alert and calm.

Formula and calculation method

RASS is a clinical ordinal scale from +4 to -5 based on agitation, alertness and response to voice/physical stimulation.

Method: Select the observed clinical state; no arithmetic formula is used.

Revised Cardiac Risk Index

Perioperative cardiac risk score.

RCRI

High-risk surgery

Ischemic heart disease

Heart failure

Stroke or TIA

Insulin therapy

Creatinine >2 mg/dL

RCRI Score

Low risk by RCRI.

Formula and calculation method

One point is assigned for each of six predictors.

Formula: RCRI = sum of high-risk surgery, ischemic heart disease, heart failure, stroke/TIA, insulin therapy, and creatinine >2 mg/dL.

Caprini VTE Risk Score

Simplified surgical VTE risk estimation.

VTE

Age

Minor surgery planned

Major surgery >45 min

BMI >25

Swollen legs / varicose veins

Prior VTE

Cancer

Known thrombophilia

Caprini Score

Very low risk in this simplified tool.

Formula and calculation method

This simplified implementation adds points for common Caprini variables. It does not include every original Caprini item.

Formula: simplified score = sum of selected weighted risk factors. Use local surgical VTE prophylaxis policy.

Pathophysiology of Failed Spinal in a Patient with History of Scorpion Bite

Image 1: LEARNING GOALS: - Understand the proposed mechanisms of spinal anaesthesia failure / inadequate block after previous scorpion sting. - Differentiate true failed spinal from apparent failure due to technical or clinical factors. - Know the anaesthetic implications, evaluation, and management strategy. MINI-INDEX (ROADMAP): - Definition, clinical context & evidence overview - Core pathophysiology & proposed mechanisms - Why the spinal fails or appears to fail - Evaluation, anaesthetic approach & management - Exam pearls, viva points & references HIGH-YIELD EXAM PEARLS: - Previous scorpion sting has been associated in case reports/series with inadequate neuraxial and local anaesthetic effect. - The mechanism is PROPOSED, not definitively proven. - Differentiate remote healed sting from active/recent envenomation. - Failed spinal is often multifactorial: drug, technique, spread, patient factors, and possible altered nerve response. REMEMBER: - History matters: ask about previous scorpion sting, number of stings, timing, and previous failed local/spinal blocks. Image 2: Definition: - Failed spinal / inadequate subarachnoid block is the absent, partial, patchy, delayed, or short-lived sensory-motor block despite intended intrathecal injection. Why This History Matters: - Reports of previous scorpion sting associated with reduced efficacy of spinal, epidural, and local infiltration anaesthesia. - However, evidence is limited and largely from case reports, case series, observational studies, and review articles. Clinical Context: - Differentiate: - Remote healed past sting - Repeated stings - Recent / active envenomation - Active envenomation causes autonomic and cardiopulmonary instability. - Remote history raises concern for possible altered local anaesthetic response. Core Concept: - No single mechanism is definitively proven. - Proposed mechanisms include: - Persistent ion-channel changes - Altered nerve membrane excitability - Receptor / nerve sensitivity changes - Autonomic-neurohumoral effects Important Caution: - A history of scorpion bite does NOT exclude ordinary causes of failed spinal such as: - Wrong space - Low dose - Leakage - Poor spread - Malposition - Drug error Block Pattern Reported: - Finding: - Delayed onset - Patchy block - No block - Short duration - Possible Explanation: - Altered sensitivity / technical factor - Maldistribution / technical issue - Failed intrathecal delivery or marked reduced response - Low dose / poor spread / possible altered response Image 3: Venom Action: - Scorpion venom contains neurotoxins acting mainly on sodium channels; also influences potassium and calcium channel behavior. - Venom neurotoxins act on voltage-gated Na+, K+, and Ca2+ channels Proposed Long-Term Mechanisms: - altered sodium-channel conformation or kinetics - altered nerve membrane excitability - possible change in local pH / perineural environment during acute phases - repeated sting exposure hypothesized to sensitize or modify channel response - altered autonomic-neurohumoral state Autonomic Nervous System: - Sympathetic: ↑HR, ↑BP, Mydriasis, Sweating - Parasympathetic: Bronchospasm, Nausea Vomiting, Urinary retention How Spinal Anaesthesia Normally Works: - Intrathecal local anaesthetic blocks Na+ channels in nerve roots - Interrupts action potential conduction - Results in sensory, motor, and sympathetic block Why Block May Become Inadequate: - If channel behavior / nerve susceptibility is altered, usual dose may show: - delayed onset - incomplete fixation - lower block height - shortened effect Evidence Note: - This mechanism is HYPOTHETICAL / PROPOSED; strong mechanistic proof is lacking Exam Pearl: - Remote history suggests possible resistance; recent active envenomation additionally causes unstable physiology and should not be confused with pure pharmacologic block failure Image 4: Section A: True Reduced Response / Possible Resistance - Delayed onset - Lower-than-expected block height - Patchy sensory block - Inadequate motor block - Need for conversion to general anaesthesia Section B: Ordinary Causes of Failed Spinal - Incorrect space / not intrathecal - CSF not truly confirmed - Drug leakage - Inadequate dose or wrong baricity - Expired / drug error - Poor positioning - Obesity / spinal deformity - Rapid CSF loss or maldistribution Section C: Apparent Failure in Scorpion-Bite Patient - Anxiety / restlessness - Pain perception mismatch - Urgent surgery - Haemodynamic instability - Active autonomic features (sweating, tachycardia, hypertension, etc.) - Incomplete assessment - Surgeon starting too early Section: True Failure vs Apparent Failure - CSF return: - True failed spinal: Absent or doubtful - Apparent / confounded failure: Present and free-flowing - Onset pattern: - True failed spinal: No onset or minimal even after adequate time - Apparent / confounded failure: Partial or patchy onset, seems inadequate - Sensory level: - True failed spinal: No significant level achieved - Apparent / confounded failure: Some level present but less than expected - Haemodynamics: - True failed spinal: Unchanged (except baseline) - Apparent / confounded failure: Change due to pain/anxiety/autonomic activity - Response to repeat block / GA: - True failed spinal: Improves only after repeat block or GA - Apparent / confounded failure: Often improves with time, sedation, or reassurance Section: Differential Diagnosis - Inadequate block - Unilateral block - Pseudo-failure (confounded by anxiety / urgency) - High anxiety - Pain from non-covered dermatome - Tourniquet pain Section: Decision Mini-Algorithm - Suspect failed spinal - Reassess sensory level and time elapsed - Check technique and vitals - CSF confirmed? - Needle / drug? - Positioning? - Vitals stable? - Decide: Repeat neuraxial vs convert to GA Section: Warning - Repeated blind attempts increase risk of PDPH, trauma, and delay. Have a backup plan. Image 5: 1) Preoperative History: - Ask timing of sting relative to current surgery - Number of past scorpion stings and their severity - Any prior failed spinal/epidural/local/regional blocks? - Any residual neurologic symptoms (weakness, numbness, paresthesia)? - Any prior cardiopulmonary complications after sting? - Is this a recent envenomation or remote past history? 2) Assessment: - Examine vitals: HR, BP, SpO2, RR, Temp - ECG - Respiratory status: air entry, work of breathing - Spine: deformity, tenderness, prior surgery, landmarks - Sensory & motor baseline expectations - Resuscitation readiness: IV access, drugs, monitors, suction, airway equipment 3) When to Suspect Genuine Altered Response: - History of repeated block failures despite expert attempts - Adequate technique with free CSF but poor/patchy block - History of failed local infiltration or peripheral nerve block after sting 4) Management of Failed Spinal in Such Patient: - Failed/inadequate spinal suspected (clinical signs or patient report) - Stop surgery if necessary - Reassess level of block, time since injection, vitals, and CSF confirmation - Provide oxygen, support ventilation if needed, treat hypotension with fluids/vasopressors - Is block clearly inadequate AND patient stable? - Consider REPEAT SPINAL ONLY IF: - Safe & appropriate - Within maximum dose limits - OR Choose EPIDURAL or COMBINED EPIDURAL-SPINAL TECHNIQUE (if expertise available) - Continue surgery with ongoing monitoring and treat complications promptly - No - Urgency HIGH or repeat neuraxial attempt doubtful? - YES - CONVERT TO GENERAL ANAESTHESIA 5) Special Cautions: - Avoid repeated traumatic punctures - Keep vasopressors (phenylephrine, ephedrine, norepinephrine) ready - Be careful in recent envenomation: risk of autonomic storm, myocarditis, pulmonary edema - Individualize plan - no "one size fits all" 6) Anaesthetic Takeaway: - In REMOTE HEALED STING, spinal may still be attempted with counselling and BACKUP PLAN in place - In RECENT SEVERE ENVENOMATION, controlled GENERAL ANAESTHESIA may be SAFER than pursuing repeated spinal attempts Image 6: Quick Exam Summary: - Previous scorpion sting has been linked with inadequate neuraxial and local anaesthetic effect. - Mechanism remains proposed, not definitively proven. - Main hypothesis: altered ion-channel/nerve membrane response to local anaesthetics. - Failed spinal in these patients is often multifactorial. - Differentiate remote past sting from active envenomation. - Always keep backup anaesthetic plan ready. Viva Questions: - Define failed spinal anaesthesia. - What mechanisms are proposed for block failure after previous scorpion sting? - How will you differentiate true failed spinal from apparent failure? - What ordinary technical causes of failed spinal must be excluded? - How will you manage an inadequate spinal in this patient? - Why may general anaesthesia be preferred in recent severe scorpion envenomation? Key Takeaway: - History of scorpion sting is a red flag for possible altered local anaesthetic response, but do not ignore common technical causes. Evidence Quality: - Available evidence is limited and heterogeneous; more mechanistic studies are needed. References: - Miller's Anesthesia. - Barash PG et al. Clinical Anesthesia. - Morgan & Mikhail's Clinical Anesthesiology. - Goldfrank's Toxicologic Emergencies. - Review articles on resistance to local anaesthetics in patients with history of scorpion sting. - Case reports/case series on inadequate subarachnoid block after previous scorpion envenomation.

Anesthesia / Pathophysiology2026-06-06 04:05:25

Open note

IV Induction Agents for Anaesthesia

Image 1: INTRODUCTION: - IV induction agents are drugs administered intravenously to produce rapid hypnosis/unconsciousness for induction of general anaesthesia. - Drug choice depends on hemodynamics, airway, intracranial status, comorbidities, and procedure. HEART: - HR - BP - CO BRAIN: - ICP - CBF ECG: - Monitor continuously - Stay safe! LUNGS: - Ventilation - Oxygenation - Airway reflexes GOLDEN RULE: - Give the right drug, in the right patient, in the right dose! INDEX - 10 PAGE SERIES: - Page 1: Cover & index - Page 2: Cove principles & general pharmacokinetics/pharmacodynamics - Page 3: Thiopentone sodium - Page 4: Methohexital + barbiturate comparison - Page 5: Propofol - Page 6: Etomidate - Page 7: Ketamine - Page 8: Benzodiazepines in induction - Page 9: Comparative PK/PD tables & clinical selection - Page 10: Viva pearls, rapid revision & references Image 2: Definition: - IV induction agents are drugs given intravenously to produce a rapid, controlled, and reversible loss of consciousness (general anesthesia) to allow airway control and surgical stimulation. Goals of Induction: - Achieve UNCONSCIOUSNESS quickly - Produce AMNESIA - Suppress AIRWAY REFLEXES (facilitate intubation) - Maintain HEMODYNAMIC STABILITY - Rapid ONSET - Predictable RECOVERY Arm-Brain Circulation Time: - Time from injection in arm vein to arrival in the brain (first pass) = 10–20 seconds in adults. Factors Affecting Onset (time to loss of consciousness): - Cerebral blood flow ↑ = faster onset - Lipid solubility ↑ = faster onset (↑ BBB penetration) - Ionization / pKa ↓ non-ionized form crosses BBB faster (lower pKa at physiologic pH = faster) - Protein binding ↑ = slower onset (less free drug) - Dose (mg/kg) ↑ = faster onset - Cardiac output ↑ = faster onset (↑ delivery to brain) Why Short Duration After A Bolus?: - After a single bolus, the drug leaves the blood and redistributes from vessel-rich organs (brain, heart, liver, kidney) to muscle and fat. - This redistribution lowers plasma concentration rapidly and explains the short duration of action. - Metabolism and excretion occur, but are NOT the main reason for the rapid offset after a bolus. Classification of IV Induction Agents: - CLASS (CHEMISTRY): - Barbiturates: Thiopentone (Thiopental) (short-acting), Methohexital (very short-acting, largely obsolete now) - Alkylphenol: Propofol (most commonly used, rapid onset, short duration) - Imidazole: Etomidate (hemodynamic stability, minimal CV depression) - Phencyclidine Derivative: Ketamine (dissociative anesthesia, analgesia, bronchodilation, ↑ HR, ↑ BP) - Benzodiazepine: Midazolam (anxiolysis, amnesia, slower onset except midazolam), Diazepam, Lorazepam (older, not ideal as sole induction agent) Ideal IV Induction Agent - Properties: - Rapid onset - Adequate depth of anesthesia - Amnesia - Minimal pain on injection - Minimal cardiovascular & respiratory depression - Stable hemodynamics - Short duration / rapid, predictable recovery - Minimal PONV - Minimal organ toxicity / safe - Inexpensive Typical IV Induction Sequence: - Pre-oxygenate 100% O2 3–5 min - Give IV Induction Agent - Assess loss of consciousness (eyelash reflex absent) - Give Neuromuscular Blocker - Maintain Anesthesia (inhalational / IV) - Confirm tube placement & Secure airway - Laryngoscopy & Intubation - Ventilate with Mask (if needed) 3 breaths Factors Influencing Choice of Induction Agent: - Patient factors: age, ASA status, comorbidities (CV, respiratory, hepatic, renal, endocrine), allergies - Hemodynamic status (stable vs unstable) - Airway considerations (anticipated difficulty, aspiration risk) - Need for rapid sequence induction (RSI)? - Duration of surgery - Need for analgesia / special properties (e.g., bronchodilation) - Drug interactions / current medications - Availability and cost Image 3: Pharmacodynamics: - Barbiturate - Positive allosteric modulation of GABA-A receptor → increased duration of Cl- channel opening - At high dose, can directly activate GABA-A receptor - Produces CNS depression Dose: - 3-5 mg/kg IV Onset: - 20-30 sec Duration: - 5-10 min (due to redistribution) Effects: - CNS Effects: - Decreases CMRO2, CBF, ICP, IOP - Anticonvulsant - Cerebral protective effect - No analgesia - CVS Effects: - Venodilation and myocardial depression → decreased SV, CO → hypotension - Reflex tachycardia may occur - Respiratory Effects: - Respiratory depression - Apnea - Blunted CO2 response - May precipitate laryngospasm if airway stimulated in light anesthesia Pharmacokinetics: - Highly lipid soluble - Unionized fraction at physiologic pH allows rapid brain entry - pKa ≈ 7.6 - Protein binding ≈ 80% - Alkaline solution: pH ≈ 10-11 (increases stability) - Rapid redistribution from vessel-rich organs (brain, heart, liver) to muscle and fat → causes awakening Redistribution (Cause of Short Duration): - Immediately after IV: High concentration in vessel-rich organs - Later: Drug moves to muscle and fat (lower concentration) → Drug in brain → awakening Adverse Effects / Complications: - Extravasation injury: pain, cellulitis, necrosis - Intra-arterial injection: severe pain and ischemia, possible gangrene - Histamine release: uncommon (flushing, hypotension, bronchospasm) - Hiccups / coughing - Risk of precipitating acute attacks in porphyria Contraindications: - Hypersensitivity to thiopentone or barbiturates - Acute intermittent porphyria - Severe hepatic impairment - Shock or severe hypotension - Significant respiratory depression / obstruction - History of extravasation injury (use alternate agent) Uses: - Induction of general anesthesia - Control of status epilepticus (IV bolus) - Short-term control of raised intracranial pressure - Facilitation of endotracheal intubation - Sedation for short diagnostic / therapeutic procedures Not used for maintenance of anesthesia. High Yield Pearl: Thiopentone → Rapid onset, short duration (due to redistribution), ↓ ICP & CMRO2, good for neuroanesthesia. Use with caution in: elderly, hypovolemia, poor cardiac reserve. Image 4: **Methohexital - Pharmacodynamics** - Oxybarbiturate - GABA-A mediated CNS depression - Induction dose: 1 - 1.5 mg/kg IV - Very rapid onset - Ultra-short action - Faster recovery than thiopentone - More excitatory phenomena / involuntary movements - Lowers seizure threshold - Proconvulsant tendency - Useful in ECT - No analgesia - Respiratory depression and hypotension possible **Methohexital - Pharmacokinetics** - Very lipid soluble - Rapid brain uptake and redistribution - Hepatic metabolism - Less accumulation than thiopentone with single use, but repeated doses can still accumulate - Short clinical duration due to redistribution - Elimination half-life longer than apparent clinical effect **Feature Comparison** - **Class** - Thiopentone (Sodium Thiopental): Barbiturate (thiobarbiturate) - Methohexital (Brevital): Barbiturate (oxybarbiturate) - **Dose (IV)** - Thiopentone: 3 - 5 mg/kg - Methohexital: 1 - 1.5 mg/kg - **Onset (IV)** - Thiopentone: 20 - 30 seconds - Methohexital: 5 - 10 seconds (very rapid) - **Duration (Clinical)** - Thiopentone: 5 - 10 minutes - Methohexital: 2 - 5 minutes (ultra-short) - **pKa / Lipid Solubility** - Thiopentone: pKa ~ 7.6 | Less lipid soluble - Methohexital: pKa ~ 7.8 - 8.0 | More lipid soluble - **CNS Effect** - Thiopentone: Potent CNS depression - Methohexital: CNS depression (less deep, briefer) - **Seizure Effect** - Thiopentone: Raises seizure threshold (anticonvulsant) - Methohexital: Lowers seizure threshold (proconvulsant tendency) - **Recovery** - Thiopentone: Slower; can be prolonged with repeated doses - Methohexital: Faster recovery than thiopentone - **Clinical Use** - Thiopentone: General anesthesia induction (less used now) - Methohexital: Induction in ECT; short procedures when rapid recovery desired - **Porphyria Issue** - Thiopentone: Porphyrinogenic - avoid in AIP - Methohexital: Less porphyrinogenic - preferred in AIP - **ECT Preference** - Thiopentone: Not preferred (longer recovery, suppresses seizure longer) - Methohexital: Preferred agent for ECT **Exam Pearl** - Methohexital is preferred for ECT because it has an ultra-short duration, allows for rapid recovery between seizures, and does not accumulate significantly with single use. It also has a proconvulsant tendency which can help produce adequate seizures. - Thiopentone recovery becomes prolonged with repeated dosing because it accumulates in body tissues (lower lipid solubility, larger volume of distribution) and has slower redistribution and hepatic metabolism, leading to prolonged CNS depression. Image 5: PHARMACODYNAMICS: - Alkylphenol IV anesthetic. - Potentiates GABA-A receptor mediated inhibitory neurotransmission. - INDUCTION DOSE: - 1.5 - 2.5 mg/kg IV in healthy adults - Lower dose ~ 1 - 1.5 mg/kg IV in elderly, frail or hypovolemic patients. - ONSET: ~ 30 sec (IV bolus) - DURATION: ~ 5 - 10 min after bolus - No analgesia. - Marked fall in SVR, preload, and myocardial contractility → HYPOTENSION; possible BRADYCARDIA. - Profound respiratory depression / apnea and suppression of airway reflexes. - Relative bronchodilator. - Decreases CMRO2, CBF, ICP, IOP - Anticonvulsant. - Antiemetic. - Antipruritic. - Smooth, clear-headed recovery. PHARMACOKINETICS: - Formulated as a LIPID EMULSION containing soybean oil, glycerol, egg phosphatide/lecithin. - Highly LIPID SOLUBLE → rapid blood-brain equilibration → rapid onset. - High protein binding (~ 95-98%). - Large volume of distribution. - Rapid redistribution from brain to peripheral tissues → short duration. - High clearance with HEPATIC CONJUGATION (gl

Anesthesia / Drugs2026-06-05 07:58:00

Open note

ECG Heart Block

Conduction Basics: - Heart block = impaired impulse conduction from atria to ventricles, usually at the AV node, His bundle, or bundle branches. - PR interval (normal): 120–200 ms. - AV block severity ranges from delay → intermittent non-conduction → complete AV dissociation. Classification Overview: - First-degree AV block: PR > 200 ms, every P conducted - Second-degree Mobitz I (Wenckebach): Progressive PR prolongation then dropped QRS - Second-degree Mobitz II: Fixed PR intervals with sudden dropped QRS - 2:1 or high-grade AV block: Every second or multiple P waves blocked - Third-degree AV block: No AV relationship, complete AV dissociation First-Degree AV Block: - ECG: PR interval > 200 ms, constant PR, each P followed by QRS - Usually asymptomatic - Causes: ↑ vagal tone, athletes, β-blockers, non-DHP CCBs (verapamil, diltiazem), digoxin, ischemia, myocarditis - Clinical pearl: Not a true dropped beat; it is conduction delay only Second-Degree AV Block - Mobitz I (Wenckebach): - ECG: Progressive PR prolongation until a non-conducted P wave occurs; then cycle repeats (Grouped beating) - Usually nodal - Often transient; vagotonia, inferior MI, drugs - Usually less likely to progress to complete heart block than Mobitz II - Management: Often observation unless symptomatic Second-Degree AV Block - Mobitz II: - ECG: PR interval constant in conducted beats with intermittent sudden dropped QRS - Usually infranodal (His-Purkinje); often associated with wide QRS - Important causes: anterior MI, fibrosis/sclerosis of conduction system, myocarditis, infiltrative disease - High risk of progression to complete heart block and syncope - Management pearl: Treat seriously; pacing usually indicated 2:1 Block / High-Grade AV Block / 2:1 Block: - 2:1 AV block: Every alternate P wave not conducted - High-grade AV block: ≥ 2 consecutive non-conducted P waves - Distinction between Mobitz I and II may be difficult in 2:1 block - Clues favoring infranodal disease: wide QRS, very low ventricular rate, structural heart disease - Emphasize careful monitoring and pacing consideration Third-Degree (Complete) AV Block: - ECG: Complete AV dissociation; P waves and QRS complexes occur independently - Atrial rate > ventricular escape rate - Junctional escape rhythm: often narrow QRS and 40–60/min - Ventricular escape rhythm: often broad QRS and 20–40/min - Symptoms: fatigue, dizziness, syncope (Stokes-Adams), hypotension, heart failure - Causes: ischemia/infarction, degeneration, post-cardiac surgery, congenital block, Lyme carditis, hyperkalemia, drug toxicity - Emergency note: Unstable patient requires immediate pacing Causes / Reversible Causes: - Ischemic heart disease / MI - Degenerative fibrosis (Lev / Lenegre) - Increased vagal tone - Drugs: β-blockers, verapamil, diltiazem, digoxin, amiodarone - Electrolytes: hyperkalemia - Myocarditis / Lyme disease - Infiltrative disease: sarcoidosis, amyloidosis - Post-procedural / post-cardiac surgery - Congenital heart block Clinical Significance & Symptoms: - None - Fatigue - Dizziness / Presyncope - Syncope (Stokes-Adams) - Dyspnea - Chest pain - Hypotension - Symptoms range from none to fatigue, presyncope, syncope, dyspnea, chest pain, hypotension - Severity depends on level of block, escape rhythm reliability, and underlying cardiac disease - Mobitz II, high-grade AV block, and complete heart block are clinically important because they may cause low cardiac output and sudden deterioration Management Summary: - Assess ABCs, vitals, symptoms, hemodynamic stability - Stop AV nodal blocking drugs if appropriate - Check ECG, electrolytes, troponin, drug history, ischemia/infection clues - Symptomatic bradycardia: Atropine 0.5 mg IV q3–5 min (max 3 mg) – may help if nodal block; usually ineffective in infranodal block - If unstable (hypotension, altered mental status, ischemia, shock, HF): Transcutaneous pacing immediately; Transvenous pacing as needed - Permanent pacemaker usually indicated for Mobitz II, high-grade AV block, or complete heart block not due to reversible cause - Treat the underlying cause Exam Pearls / Viva Points: - PR > 200 ms = first-degree AV block - Wenckebach = progressive PR prolongation before dropped beat - Mobitz II = fixed PR with dropped beat = dangerous - Third-degree block = AV dissociation - Wide QRS often suggests infranodal disease - Inferior MI more often causes nodal block; anterior MI more often causes infranodal block - Atropine may help nodal block; usually ineffective in infranodal block - Always look for reversible causes - Pacing indicated in symptomatic patients or high-risk blocks

Anesthesia2026-06-02 08:16:49

Open note

Volatile Anaesthetics

Image 1: High-yield anaesthesia notes for Paper I topic 3 - Volatile anaesthetics are inhaled anaesthetic vapours delivered via a vaporizer. They are used for induction (with IV agents) and maintenance of general anaesthesia. SMALL INDEX: - Page 2: Basics & key concepts - Page 3: Bronchomotor tone - Page 4: Bronchospasm in OT - Page 5: Nephrotoxicity - Page 6: Risk reduction & agent comparison - Page 7: Clinical pearls & pitfalls - Page 8: Viva questions + references MEMORY AID: - Sevo → smooth airways - Des → irritant - Methoxy → renal toxicity Image 2: Examples: - Sevoflurane - Isoflurane - Desflurane - Halothane - Enflurane - Methoxyflurane (historical) - Nitrous oxide (N2O) Mechanism: - Enhance inhibitory transmission (especially GABA-A / glycine) - Reduce excitatory transmission (NMDA and nicotinic pathways) - Alter ion channels (e.g. K+, Ca2+, Na+ channels) - Depress CNS in a dose-dependent manner MAC: - MAC = alveolar concentration preventing movement in 50% of patients to surgical skin incision - Low MAC = high potency - ~ 1.3 MAC prevents movement in ~ 95% - MAC decreases with: ↑ age, pregnancy, opioids, sedatives, hypothermia Agent Properties: - Sevoflurane: - Approx MAC (%): ~ 2.0 - Blood:gas coefficient: 0.65 - Airway note: Smooth, non-pungent - Isoflurane: - Approx MAC (%): ~ 1.15 - Blood:gas coefficient: 1.4 - Airway note: Pungent but bronchodilator - Desflurane: - Approx MAC (%): ~ 6.0 - Blood:gas coefficient: 0.42 - Airway note: Fastest, pungent, airway irritant - N2O (nitrous oxide): - Approx MAC (%): 104 - Blood:gas coefficient: 0.47 - Airway note: Weak, adjunct Exam Pearl and Memory Aid: - Potency is described by MAC - Speed is described by blood:gas solubility - Lower MAC = more potent - Lower blood:gas = faster induction & recovery - POTENT = LOW MAC - FAST = LOW BLOOD:GAS - Think: "Low numbers, low solubility → GO FAST!" Image 3: Mechanisms: - Direct airway smooth muscle relaxation - Reduced intracellular Ca2+ availability - Reduced myofilament Ca2+ sensitivity - K+ channel effects / hyperpolarisation - Reduced vagal reflex bronchoconstriction Agent differences: - Sevoflurane = least pungent, smooth inhalational induction, preferred in reactive airways - Isoflurane = bronchodilator but pungent - Desflurane = pungent, may provoke cough, breath-holding, laryngospasm, increased airway resistance when concentration rises rapidly Use in asthma/COPD: - Use adequate anaesthetic depth - Use humidified gases - Consider bronchodilator adjuncts (e.g. β2-agonists, anticholinergics) Exam Pearl: - Drug property alone is not enough - inadequate anaesthetic depth during airway manipulation can still cause bronchospasm. Image 4: Recognition: - Increased peak airway pressure - Wheeze or silent chest - Difficulty bagging - Prolonged expiration - Desaturation - Shark-fin capnogram Differential / exclude first: - Tube kink or obstruction - Secretions - Endobronchial intubation - Light anaesthesia - Anaphylaxis - Pneumothorax Management - stepwise approach: - 100% O2 and CALL HELP - Hand-ventilate and assess resistance - Deepen anaesthesia with sevoflurane or isoflurane or propofol - Salbutamol via circuit (MDI 4-8 puffs or nebuliser) - Add Ipratropium via circuit (MDI 4 puffs or nebuliser) - Steroids (e.g. Hydrocortisone 100 mg IV) - Magnesium sulfate (e.g. 2 g IV over 10-20 min) - Adrenaline if severe or anaphylaxis (e.g. 10-50 mcg IV bolus, repeat PRN) - Ventilate with LOW RR and LONG EXPIRATORY TIME to avoid air trapping Exam Pearl: - Ketamine can be helpful because it supports bronchodilation. Memory Aid: - Shark-fin capnogram = bronchospasm until proven otherwise. Image 5: Nephrotoxicity: - Volatile-related renal toxicity is classically associated with methoxyflurane. - Sevoflurane has a much smaller and more controversial renal concern. Methoxyflurane: - Extensive metabolism - High inorganic fluoride production - Dose-related polyuric renal failure / nephrogenic diabetes insipidus - Now obsolete for routine general anaesthesia Sevoflurane: - Metabolism produces fluoride - Degradation by CO2 absorbent can form Compound A - Risk rises with low-flow anaesthesia, dry absorbent, heat and high concentration - Clinically significant nephrotoxicity in routine humans is not consistently proven Pathway to renal risk: - Volatile agent → Metabolism / absorbent interaction → Fluoride or Compound A → Renal tubule exposure → Renal risk Metabolism (relative amount): - Methoxyflurane: VERY HIGH - Sevoflurane: LOW - Isoflurane: VERY LOW - Desflurane: MINIMAL Exam Pearl: - Classic answer = methoxyflurane; modern discussion = sevoflurane + Compound A Image 6: RISK FACTORS: - CKD (chronic kidney disease) - Elderly age - Dehydration / hypovolaemia - Hypotension / low MAP - Sepsis / systemic inflammation - Concomitant nephrotoxins (e.g. NSAIDs, aminoglycosides, radiocontrast) - Diabetes mellitus - Major surgery / prolonged duration - Poor renal reserve PREVENTION & BEST PRACTICE: - Maintain MAP and renal perfusion (MAP ≥ 65 mmHg unless otherwise indicated) - Avoid prolonged hypotension - Maintain euvolaemia (avoid both hypo- and hypervolaemia) - Avoid desiccated CO2 absorbent - Follow low-flow anaesthesia (use manufacturer recommendations) - Monitor urine output and creatinine in high-risk patients Agent Properties: - Sevoflurane: - Airway effect: Bronchodilator, non-pungent - Renal note: Compound A concern but usually safe clinically - Typical practical use: Inhalational induction, reactive airways - Isoflurane: - Airway effect: Bronchodilator but pungent - Renal note: Minimal renal concern - Typical practical use: Economical maintenance - Desflurane: - Airway effect: Airway irritant - Renal note: Minimal metabolism - Typical practical use: Rapid emergence, short procedures - Methoxyflurane (historical): - Airway effect: Not used for routine GA - Renal note: Classic fluoride nephrotoxicity - Typical practical use: Historical agent (obsolete) EXAM PEARL: - Metabolism alone does not equal toxicity – context, dose, duration and patient reserve matter. REMEMBER: - Good perfusion + euvolemia + sensible technique = kidneys stay happy! Image 7: Asthma / COPD: - Prefer Sevoflurane (least airway irritation among volatiles). - Ensure adequate depth before instrumentation. - Continue bronchodilators (pre-op and intra-op). - Use long expiratory time to prevent air trapping and dynamic hyperinflation. Desflurane pitfall: - Avoid Desflurane for inhalational induction and in patients with active reactive airway disease. - It is very pungent and causes airway irritation → coughing, laryngospasm, bronchospasm. MH warning: - All potent volatile agents (sevoflurane, isoflurane, desflurane, halothane, enflurane) are MALIGNANT HYPERTHERMIA triggers. - Avoid in susceptible patients and use trigger-free anaesthesia (TIVA ± nitrous if appropriate). - Have dantrolene and MH protocol ready. Neuro / ICP: - Volatile agents reduce CMRO2 (dose-dependent) → neuroprotective. - BUT at higher doses they cause cerebral vasodilation → ↑ CBF and ↑ ICP, especially with hypercapnia. - Keep normocapnia (PaCO2 4-5 kPa / 35-45 mmHg) to avoid ↑ ICP. Obstetric note: - High concentrations of volatile agents can relax uterine smooth muscle. - This can increase risk of uterine atony and postpartum haemorrhage. - Use the lowest effective concentration and monitor uterine tone closely. Image 8: Section heading: - Define MAC: - Alveolar concentration preventing movement in 50% of patients to skin incision. - Low MAC = high potency. Section heading: - Why is sevoflurane preferred in reactive airways? - Least pungent - Smooth induction - Bronchodilator effect Section heading: - Why can desflurane worsen airway responses? - Pungency and rapid concentration rise can provoke cough, laryngospasm and increased airway resistance. Section heading: - Which volatile is classically nephrotoxic? - Methoxyflurane, because extensive metabolism produces inorganic fluoride. Section heading: - What is Compound A? - A sevoflurane degradation product formed with CO2 absorbents, especially under low-flow / dry absorbent conditions. Section heading: - How do you manage intraoperative bronchospasm? - 100% O2 - Deepen anaesthesia - Exclude mechanical causes - Bronchodilators (β2-agonists / anticholinergics) - Adjuncts (MgSO4, IV steroids) - Adrenaline if severe / refractory Section heading: - Which agents trigger malignant hyperthermia? - All potent volatile anaesthetics and suxamethonium.

Anesthesia / Drugs2026-05-31 05:24:46

Open note

Cardiac Anatomy and Function

Cardiac Anatomy & Function: - Oxygen delivery meets demand - Structure → Function → Perfusion Basic Physiology for Anaesthetists: - SVC → RA → RV → LV → Aorta - IVC → RA → RV → LV → Aorta - LA → LV → Aorta Coronary Supply: - LCA → LAD, LCx - RCA → PDA, PLB Image 2: Structure of the Heart: - Location: thorax, enclosed in fibrous pericardium - Epicardium (visceral pericardium): outer serous layer; reduces friction - Myocardium: thick muscular layer; contracts to generate force - Endocardium: inner endothelial lining; smooth surface for blood flow Chambers overview: - Right atrium: receives deoxygenated blood from SVC and IVC - Tricuspid valve (3 cusps) - Right ventricle - Pulmonary valve (3 cusps) - Pulmonary artery to lungs for oxygenation - Left atrium: receives oxygenated blood from 4 pulmonary veins (normal variation 3-5) - Mitral valve (2 leaflets) - Left ventricle - Aortic valve (3 cusps) - Aorta to systemic circulation Ventricles - key differences: - RIGHT VENTRICLE (RV): Crescent-shaped in transverse plane, Triangular in longitudinal section, Difficult to estimate volumes by echo - LEFT VENTRICLE (LV): Circular in transverse section, Conical in longitudinal section, Easier for echocardiographic volume estimation General: - The heart is a muscular organ that ejects blood into the vascular system - The right side generates flow to the pulmonary circulation, the left side generates pressure to the systemic circulation - The heart also has an endocrine role via ANP and BNP in plasma volume regulation - The heart is commonly called a pump, but technically, it does NOT "suck" blood from the venous system because negative pressure would collapse compliant veins - Right side → generates FLOW (low pressure), Left side → generates PRESSURE (high pressure) Image 3: Functional Syncytium: - Myocardium arranged in networks of striated cardiac muscle cells joined by intercalated discs. - Intercalated discs contain 3 interactions: - Gap junction complexes: direct passage of ions and larger molecules; electrical spread of AP without neurotransmission. - Fascia adherens: anchor actin filaments within sarcomere to cell membrane. - Macular adherens / desmosomes: anchor cardiac cells to one another. Why Coronary Circulation is Needed: - Ventricular wall too thick for effective O2 diffusion; only endocardium nourished directly. - Bulk of myocardium perfused by coronary arteries. - Coronary arteries are end arteries with few anastomoses → acute obstruction causes myocardial ischemia. Aortic Root & Sinuses of Valsalva: - Three dilatations above aortic valve. - Create eddy currents keeping valve cusps away from wall and facilitating smooth closure. - Prevents occlusion of coronary ostia. Left Coronary Artery: - Left coronary artery (left main stem) arises from left posterior aortic sinus, travels <2.5 cm in left AV groove. - Bifurcates into: - Left interventricular artery / LAD: - Descends in anterior interventricular groove. - Gives septal and diagonal branches. - Supplies anterolateral myocardium, apex, interventricular septum. - Often anastomoses with posterior interventricular artery after passing apex. - Left circumflex artery: - Continues in left AV groove. - Gives obtuse marginal branches. - Forms anastomosis with right coronary in AV groove. - Supplies posterolateral LV and SA node in 40%. Coronary Arteries: - Coronary arteries arise from the aortic root, not from the ventricular cavities. - Right coronary artery arises from right anterior aortic sinus. - Left coronary artery arises from left posterior aortic sinus. Image 4: Right Coronary Artery (RCA): - arises from anterior aortic sinus, just above right cusp of aortic valve. - travels along right AV groove. - branches: - SA nodal branch present in 60% - supplies SA node. - Right marginal artery - runs down right margin toward apex; supplies right ventricle; right-sided equivalent of LAD. - RCA continues in AV groove to posterior interventricular groove, then usually gives posterior interventricular artery / posterior descending artery. - posterior interventricular artery supplies posterior part of septum and AV node. - RCA then continues in AV groove to anastomose with left circumflex artery. Coronary Dominance: - most people are right dominant. - left dominance = posterior interventricular artery arises from left circumflex artery. occurs in around 15% of population. Memory Tip: - Dominance is defined by which artery gives the posterior descending artery (PDA). Artery Information: - Right coronary artery (RCA) - ARTERY: Right coronary artery (RCA) - COURSE: arises from anterior aortic sinus (above right cusp) → travels in right AV groove → continues to posterior interventricular groove → then in AV groove to anastomose with LCx - BRANCHES: - SA nodal branch (present in 60%) - Right marginal artery - Posterior interventricular artery (PDA / PIA) - SUPPLY: - SA node (in 60%) - Right ventricle - Posterior septum - AV node - Left circumflex artery (LCx) - ARTERY: Left circumflex artery (LCx) - COURSE: arises from left aortic sinus → travels in left AV groove → continues in AV groove to anastomose with RCA - BRANCHES: - Obtuse marginal arteries (may give PDA in left dominance) - SUPPLY: - Left ventricle (posterolateral wall) - SA node (in 40%) - Left anterior descending artery (LAD) - ARTERY: Left anterior descending artery (LAD) - COURSE: arises from left aortic sinus → travels in anterior interventricular groove to apex - BRANCHES: - Septal perforators - Diagonal branches - SUPPLY: - Anterolateral LV - Apex - Septum (anterior 2/3) Territory Summary: - LAD → anterolateral LV, apex, septum. - LCx → posterolateral LV, SA node in 40%. - RCA → RV, SA node in 60%, AV node, posterior septum Image 5: Three venous drainage systems: - Coronary sinus: - drains venous blood from LV; accounts for ~85% of venous drainage. - formed by cardiac veins; opens into right atrium between IVC and tricuspid valve. - veins follow grooves like coronary arteries. - key tributaries: - Great cardiac vein - alongside left interventricular artery in anterior interventricular groove. - Middle cardiac vein - alongside posterior interventricular artery in posterior interventricular groove. - Small cardiac vein - alongside right coronary artery in posterior AV groove. - Oblique vein - traverses back of left atrium. - Anterior cardiac veins: - small veins from anterior surface of RV. - drain directly into right atrium. - Thebesian veins: - smallest cardiac veins. - drain directly into all four chambers, predominantly right atrium and right ventricle. Summary – comparison of venous drainage systems: - DRAINAGE SYSTEM: 1. Coronary sinus 2. Anterior cardiac veins 3. Thebesian veins - MAJOR SOURCE: 1. Great cardiac vein, Middle cardiac vein, Small cardiac vein, Oblique vein (~85% of venous drainage) 2. Anterior surface of right ventricle (small veins) 3. Myocardium of all chambers (very small veins) - DRAINS INTO: 1. Right atrium (between IVC and tricuspid valve) 2. Right atrium 3. All four chambers (predominantly RA & RV) CLINICAL NOTE: - Thebesian veins draining into left side introduce small amount of deoxygenated blood into oxygenated stream → contribute to physiological shunt. VIVA POINT: - Coronary sinus is important for placement of the left ventricular lead in CRT. Image 6: ECG changes in myocardial ischaemia: - ECG is the key investigation in acute myocardial ischaemia and infarction. Abnormalities may involve depolarization (Q-wave) and repolarization (ST segment, T-wave). ECG pattern depends on the extent and location of ischaemia. Extent of ischaemia: - Subendocardial ischaemia/infarction → ST segment depression. - Subepicardial or transmural infarction → ST segment elevation. Localization of ischaemia: - Region: - Inferior wall: Leads II, III, aVF; Arterial supply: RCA + posterior interventricular artery; Key consequence: hypotension and bradycardia possible because RCA often supplies SA node. - Lateral wall: Leads I, II, V5, V6; Arterial supply: circumflex artery; Key consequence: LV dysfunction. - Septal: Leads V1, V2; Arterial supply: septal branch of LAD; Key consequence: bundle branch block possible because septum contains bundle of His. - Apical: Leads V3, V4; Arterial supply: terminal LAD or posterior interventricular artery in right-dominant circulation; Key consequence: LV dysfunction. - Anterior wall: Leads I, aVL, V1-V6; Arterial supply: LAD; Key consequence: severe LV dysfunction due to large territory. - Posterior wall: ST depression in V1-V4; Arterial supply: circumflex + posterior interventricular artery; Key consequence: LV dysfunction; difficult to diagnose. Memory Aids and Exam Pearls: - Anterior MI = LAD = largest LV territory = most dangerous. - Posterior wall infarction often shows reciprocal-looking ST depression in anterior leads. Image 7: Cardiac Resynchronization Therapy (CRT): - some severe heart failure patients have conduction defects causing ventricular dyssynchrony. - dyssynchrony reduces stroke volume and delays ventricular relaxation. - indication: sinus rhythm + EF <35% + widened QRS / conduction defect with asynchronous right and left ventricular contraction. - CRT uses 3 pacemaker wires: atrial, right ventricular, left ventricular. Is Myocardial Blood Flow Continuous? - The resting heart receives ~250 mL/min of blood, about 5% of cardiac output. - Coronary blood flow can increase up to fivefold during strenuous exercise. - Myocardial O2 extraction is about 70% at rest; skeletal muscle at rest about 25%. - T

Anesthesia / Physiology / CVS2026-05-30 13:45:23

Open note

Frozen Shoulder Protocol

**Phase 1: Pain Control & Early Mobility (Freezing Stage, 0-6 weeks)** - Reduce pain - Minimize inflammation - Maintain available ROM - Prevent further stiffness **Interventions:** - Pendulum (Codman) Exercise: 3-5 min, 2-3x/day - Table Slide (Flexion): 10-15 reps, 2-3x/day - Wand Assisted Flexion (Supine): 10-15 reps, 2-3x/day - Scapular Setting: 10 reps, 2-3x/day (5 sec hold) - Pain Relief Modalities: Ice / TENS / Ultrasound / Moist heat, as per need **Precautions:** - Avoid pushing through pain - No heavy activities - Avoid lifting overhead - Sleep with support under arm if needed **Phase 2: Improve ROM & Flexibility (Frozen Stage, 6-12 weeks)** - Improve ROM (especially ER, Abduction) - Reduce stiffness - Improve joint mobility **Interventions:** - Wand Assisted External Rotation: 10-15 reps, 2-3x/day - Cross Body Stretch: 20-30 sec hold, 3 reps, 2-3x/day - Sleeper Stretch (ER): 20-30 sec hold, 3 reps, 2-3x/day - Wall Slide (Abduction): 10-15 reps, 2-3x/day - Joint Mobilization (Physiotherapist): Grade II-IV, 3-4 sets, as tolerated **Precautions:** - Stretch till mild discomfort (not sharp pain) - Avoid ballistic movements - Maintain good posture **Phase 3: Strength & Function (Thawing Stage, 12-10 weeks)** - Restore full ROM - Improve strength - Enhance functional use - Return to activities **Interventions:** - Theraband – External Rotation: 10-15 reps, 2-3 sets, 3-4x/week - Theraband – Internal Rotation: 10-15 reps, 2-3 sets, 3-4x/week - Shoulder Flexion with Dumbbell: 10-15 reps, 2-3 sets, 3-4x/week - Scaption Raise: 10-15 reps, 2-3 sets, 3-4x/week - Functional Training: Functional progression, 3-4x/week **Precautions:** - Progress gradually - Stop if pain increases > 2/10 - Focus on quality of movement **Phase 4: Maintenance & Prevention (20+ weeks, Ongoing)** - Maintain ROM & strength - Prevent recurrence - Promote shoulder health **Interventions:** - Regular Stretching Routine: Ongoing program - Strength Training: 2-3x/week, 2-3x/week minimum - Posture & Ergonomics - Active Lifestyle **Precautions:** - Listen to your shoulder - Avoid long periods of inactivity - Maintain overall fitness

Physiotherapy / Protocol2026-05-30 03:11:05

Open note

Goldman Cardiac Risk Index & RCRI

RCRI estimates the risk of MAJOR CARDIAC COMPLICATIONS after MAJOR NONCARDIAC SURGERY. Image 1: Why This Topic Matters: - Surgery and anesthesia stress the heart. - Patients may develop life-threatening cardiac complications in the perioperative period. - Major Adverse Cardiac Events (MACE): - Perioperative myocardial infarction (MI) - Pulmonary edema / acute heart failure - Ventricular fibrillation / cardiac arrest - Complete heart block - Used BEFORE NONCARDIAC surgery to estimate risk and guide management. Historical Timeline: - 1977: Goldman multifactorial cardiac risk index - 1999: Lee et al. Revised Cardiac Risk Index (RCRI) Goldman vs RCRI: - FEATURE - Year - Goldman Index: 1977 - RCRI: 1999 - Complexity - Goldman Index: More complex, multifactorial - RCRI: Simpler, focused on key predictors - Variables - Goldman Index: Multiple cardiac + noncardiac factors (clinical + ECG) - RCRI: 6 cardiac risk predictors - Practicality - Goldman Index: More time-consuming - RCRI: Quick, easy to remember & use - Current Use - Goldman Index: Historical / less commonly used - RCRI: Widely taught and used - Typical Role - Goldman Index: More detailed risk estimation; foundation for earlier research - RCRI: Standard clinical tool for routine preoperative risk stratification What does RCRI predict? - RCRI estimates the risk of MAJOR CARDIAC COMPLICATIONS after MAJOR NONCARDIAC SURGERY. - It helps clinicians: - Decide if further cardiac evaluation is needed - Plan perioperative monitoring and resources - Guide perioperative medical optimization Pearl: - RCRI is a CLINICAL prediction rule – it does NOT replace clinical judgment, functional capacity assessment, or guideline-directed evaluation. Core Idea: - Each predictor counts as 1 POINT. - Higher total score = higher perioperative cardiac risk. Modern Era: - Used with guideline-based perioperative assessment and sometimes alongside NSQIP / MICA. Image 2: Concept: - Goldman created a weighted multifactorial index for predicting serious perioperative cardiac complications in noncardiac surgery. Predictors & Points: - S3 gallop or elevated JVP: 11 points - Myocardial infarction within previous 6 months: 10 points - >5 premature ventricular contractions per minute preoperatively: 7 points - Rhythm other than sinus or presence of PACs on preoperative ECG: 7 points - Age >70 years: 5 points - Emergency operation: 4 points - Intraperitoneal, intrathoracic, or aortic surgery: 3 points - Important aortic stenosis: 3 points - Poor general medical condition: 3 points Poor General Medical Condition Includes: - Hypoxemia - Significant electrolyte or acid-base disturbance - Renal dysfunction - Hepatic dysfunction - Bedridden / poor systemic status Risk Classes: - Class I: 0-5 points - Class II: 6-12 points - Class III: 13-25 points - Class IV: ≥26 points Strengths / Weaknesses: Strengths: - Historically seminal - Introduced structured perioperative cardiac risk assessment Weaknesses: - Cumbersome, weighted variables - Depends partly on ECG findings - Less practical now - Largely replaced by simpler models Take-Home Pearl: - Goldman index is high-yield for exams and history of perioperative medicine, but RCRI is more commonly used in routine practice. - Approx historical life-threatening cardiac complication rate in derivation cohort rose markedly across classes (~1%, 7%, 14%, 78%). Image 3: How Scoring Works: - Each variable = 1 point - Total score = 0–6 Original Endpoint: - Predicts risk of MAJOR CARDIAC COMPLICATIONS: - Myocardial infarction (MI) - Pulmonary edema - Ventricular fibrillation or primary cardiac arrest - Complete heart block 6 Predictors - 1 Point Each: - High-risk surgery: intraperitoneal, intrathoracic, or suprainguinal vascular surgery - History of ischemic heart disease: prior MI, positive stress test, typical angina/current ischemic chest pain, nitrate therapy, or pathologic Q waves - History of congestive heart failure: prior HF/pulmonary edema/PND, bilateral rales or S3, or pulmonary vascular congestion - History of cerebrovascular disease: prior stroke or TIA - Diabetes mellitus requiring insulin therapy - Preoperative serum creatinine >2.0 mg/dL (177 micromol/L) Memory Line: - High-risk surgery + IHD + CHF + CVA + insulin DM + Cr >2 Clinical Pearl: - RCRI is simple and fast, but it estimates risk — it does not itself dictate stress testing or cancellation of surgery Compared to Goldman: - Unlike Goldman, RCRI uses six binary variables with equal weight. Image 4: RISK CLASSES: - Original Lee et al. rates for major cardiac complications - RCRI SCORE (# OF PREDICTORS) - 0 PREDICTORS: CLASS I, 0.4% APPROX. RISK OF MAJOR CARDIAC COMPLICATIONS - 1 PREDICTOR: CLASS II, 0.9% APPROX. RISK OF MAJOR CARDIAC COMPLICATIONS - 2 PREDICTORS: CLASS III, 6.6% APPROX. RISK OF MAJOR CARDIAC COMPLICATIONS - ≥3 PREDICTORS: CLASS IV, 11.0% APPROX. RISK OF MAJOR CARDIAC COMPLICATIONS - Major cardiac complication = MI, pulmonary edema, VF/cardiac arrest, or complete heart block HOW TO READ IT CLINICALLY: - 0 = low perioperative cardiac risk - 1 = mildly increased risk - 2 = clearly elevated risk - ≥3 = high risk; consider more intensive perioperative planning STRENGTHS: - Simple - Bedside - Reproducible - Externally validated - High-yield teaching tool LIMITATIONS: - Calibration varies in modern populations - May underestimate risk in some vascular surgery patients - Does not include frailty, age, functional capacity/METs, biomarkers, active valvular disease, urgency, or intraoperative factors - Should not be used as the only decision-maker OTHER TOOLS: - Other tools such as NSQIP MICA / ACS NSQIP may offer procedure-specific individualized estimates in some settings. Image 5: Practical Stepwise Approach: - Determine urgency of surgery (emergent / urgent / elective). - Look for active unstable cardiac conditions: - Acute coronary syndrome / unstable angina - Decompensated heart failure - Significant arrhythmia - Severe valvular disease - Estimate surgical risk and calculate RCRI. - Assess functional capacity (METs): if ≥4 METs and no unstable features, often proceed without further testing. - If elevated risk and poor / unknown functional capacity, consider biomarkers and/or noninvasive testing only if results will change management. - Optimize perioperative plan: monitoring, medications, postoperative surveillance. Medication Pearls: - Continue chronic beta-blockers; do not start high-dose beta-blocker on day of surgery. - Continue statins, especially for vascular surgery patients. - Antiplatelet and anticoagulant decisions are individualized. - Consider postoperative troponin surveillance in selected high-risk patients. Important Pitfalls: - Not designed for cardiac surgery. - Do not use RCRI alone to cancel surgery. - Combine with surgical factors, history, exam, ECG, functional capacity, and guidelines. - Absolute risk may differ from the original 1999 cohort. RCRI vs Other Tools: - RCRI: simplest bedside score. - NSQIP MICA/ACS NSQIP: more individualized procedure-specific risk estimation.

Anesthesia / PYQ / CVS2026-05-15 04:36:13

Open note

Succinylcholine Depolarizing Neuromuscular Blocker

Image 1: What is it: - Only clinically used depolarizing neuromuscular blocker - Also called suxamethonium Structure: - Two acetylcholine (ACh) molecules linked together - Quaternary ammonium compound - Poor oral absorption - Does not cross BBB significantly Core Mechanism at NMJ: - Agonist at nicotinic Nm receptor - Persistent end-plate depolarization - Initial fasciculations - Flaccid paralysis Sequence of Paralysis: - Small, rapidly moving muscles first → eyes, jaw, facial muscles, larynx - Then limbs and trunk - Diaphragm (respiratory muscles) last - Recovery occurs in REVERSE order Onset & Duration: - IV onset: usually 30–60 seconds - Excellent intubating conditions: ~ 45–60 seconds - Clinical duration: ~ 5–10 minutes after usual IV dose (1–1.5 mg/kg) Metabolism & Termination: - Rapidly hydrolyzed in plasma by butyrylcholinesterase (pseudocholinesterase) - Not metabolized by acetylcholinesterase at synapse - Only a small fraction reaches the NMJ intact Phase I vs Phase II Block: - Phase I Block (Depolarizing Block): - Occurs when: Usual clinical dose (1–1.5 mg/kg IV) - Mechanism: Persistent depolarization of end-plate - Fasciculations: PRESENT (initially) - TOF (Train-of-Four): No fade (all four twitches equal) - Post-Tetanic Facilitation: Absent - Response to Anticholinesterases: Do NOT reverse block and may PROLONG it - Phase II Block (Desensitizing Block): - Occurs when: After large doses or repeated administration - Mechanism: Receptor desensitization (cannot be depolarized) - Fasciculations: ABSENT - TOF (Train-of-Four): Fade present - Post-Tetanic Facilitation: May be present - Response to Anticholinesterases: May partially reverse (like nondepolarizers) Pharmacokinetic Pearls: - Redistribution has limited role - Action PROLONGED by: - Low or atypical butyrylcholinesterase - Liver disease - Pregnancy / postpartum - Organophosphates - Cholinesterase inhibitors - Severe illness (burns, sepsis, trauma, etc.) WHY SO FAST? - Low pKa → highly ionized (quaternary ammonium) - High potency at Nm receptor - Rapid delivery to NMJ via blood - Rapid hydrolysis in plasma → short duration Image 2: Main Indications: - Rapid sequence intubation (RSI) - Emergency airway control - Brief procedures requiring intense, short paralysis - Treatment of laryngospasm (small dose IV in selected settings) - Facilitation of electroconvulsive therapy (ECT) Standard Dosing: - Route: IV (intubation dose), ED/RSI (commonly IV), IM (when IV unavailable) - Dose: 1-1.5 mg/kg, 1-1.5 mg/kg, 3-4 mg/kg (max practical dose ~150 mg) - Onset: 30-60 seconds, 30-60 seconds, 2-3 minutes - Duration: ~5-10 minutes, ~5-10 minutes, Longer than IV (typically 15-20+ min) Why Favored for RSI: - Fastest onset of all neuromuscular blockers - Profound, reliable muscle relaxation - Short duration → quick recovery of spontaneous breathing - Excellent intubating conditions Succinylcholine vs. Rocuronium for RSI: - Feature: Typical RSI dose, Onset (IV), Duration, Reversibility, Major Advantages, Major Disadvantages - Succinylcholine: 1-1.5 mg/kg IV, 30-60 seconds, ~5-10 minutes, Spontaneous (no specific reversal agent), Fastest onset, ultra-short duration, excellent conditions, Hyperkalemia risk, MH risk, apnea, other adverse effects - Rocuronium: 1.0-1.2 mg/kg IV, ~45-60 seconds, ~30-60 minutes, Reversible with sugammadex, No risk of malignant hyperthermia or hyperkalemia, Longer duration unless reversed; slightly slower onset Dosing Pearls: - Weight to use: Many clinicians dose SUX to TOTAL BODY WEIGHT (TBW) in obesity because of increased pseudocholinesterase activity and larger extracellular fluid volume - Reduced dose 0.3-0.6 mg/kg may relieve laryngospasm, but may be inadequate for full intubating paralysis - Defasciculation: Give a small dose of a nondepolarizing neuromuscular blocker (e.g., rocuronium 0.1 mg/kg IV) 1-3 min before SUX to reduce fasciculations and myalgia. May slightly increase SUX intubating dose requirement Sequence of Clinical Onset (IV): - Jaw relaxation: ~30–45 sec - Cords open: ~45–60 sec - Apnea & paralysis: ~60 sec - Recovery: ~5–10 min Monitoring & Administration Reminders: - Use ONLY when airway equipment and ventilation capability are immediately available - Always give with adequate sedation or anesthesia and analgesia - Preoxygenate before administration - Confirm IV access and patency, Monitor clinical effect closely - Neuromuscular monitoring (TOF, PTC, or acceleromyography) recommended Image 3: Fasciculations: - Mechanism: brief depolarization of muscle end-plates → synchronous muscle twitches - Common after administration (almost universal) - May cause postoperative myalgia - More common in ambulatory patients / adults - Reduced by: Defasciculation (small dose nondepolarizing NMB), Lidocaine (IV 1-1.5 mg/kg), NSAIDs (e.g., ketorolac, ibuprofen) Myalgia: - Incidence variable (~10-50%) - Mechanism (theory): Muscle microtrauma from intense fasciculations → increased CK, muscle soreness - Typically affects masseter, neck, back, and extremities - Usually mild, self-limited (24-48 h) - More common in ambulatory patients and adults Bradycardia & Rhythm Effects: - Due to stimulation of cardiac muscarinic receptors (vagal effect) - More likely with: repeated doses, children, and conditions with high vagal tone - Dysrhythmias may occur (PVCs, junctional rhythm, asystole) - Atropine pretreatment (0.01-0.02 mg/kg IV) sometimes considered in pediatrics or with repeated dosing Increased Intraocular Pressure: - Transient rise begins within minutes after administration; resolves in 5-10 minutes - Due to contraction of extraocular muscles and decreased outflow - Historically relevant in open globe injury debate - Clinical decision individualized (benefits vs. risks) - Open globe injury? → Consider alternative NMB or risk mitigation Increased Intragastric & Intracranial Pressure: - Transient increase after administration - Offset by increased tone of lower esophageal sphincter - ICP increase is usually small and transient - Consider clinical context: TBI, space-occupying lesions, or uncontrolled ICP Histamine Release / Anaphylaxis: - Histamine release is generally minimal compared with some other agents - May cause flushing, hypotension, bronchospasm (rare) - Anaphylaxis can occur — as with all neuromuscular blockers Mechanism Map: From Depolarization to Effects: - Succinylcholine → Persistent depolarization at NMJ → Synchronous muscle firing → Fasciculations → Efflux of K+ → Serum potassium ↑ → Muscle fiber stress / microtrauma → Myalgia → Vagal stimulation (cardiac M2) → Bradycardia / Dysrhythmias Practical Management Pearls: - Ensure adequate depth of anesthesia before giving drug to blunt sympathetic responses. - Anticipate fasciculations — consider defasciculation or adjuncts. - Monitor ECG and hemodynamics; be prepared for bradycardia. - Be ready to ventilate and support blood pressure. - Avoid repeated doses when possible. Image 4: Hyperkalemia - Normal serum K+ rise ~ 0.5 mEq/L in healthy patients - Mechanism: Sustained depolarization → K+ efflux from muscle Dangerous Hyperkalemia Risk States - Burns after ~24-48 h and for months - Major denervation / spinal cord injury / stroke after ~24-72 h and may persist months - Prolonged immobilization / critical illness myopathy - Upper or lower motor neuron lesions - Muscular dystrophies / myopathies (especially Duchenne / Becker) - Severe infection or trauma with receptor upregulation - Rhabdomyolysis risk Malignant Hyperthermia Trigger - Succinylcholine can trigger MALIGNANT HYPERTHERMIA – especially with volatile anesthetics. - Early Signs: Rising ETCO2, Tachycardia, Muscle rigidity, Hyperthermia (later), Acidosis, Hyperkalemia - Management: - STOP triggers (SUX + volatiles) NOW - Call for HELP / activate MH protocol - Give DANTROLENE 2.5 mg/kg IV repeat as needed - Active cooling - Treat acidosis and hyperkalemia - Support ventilation and circulation Masseter Spasm / Jaw Rigidity - May occur with succinylcholine - Can be isolated but may herald MH - Do NOT assume it is a normal course Cardiac Arrest in Undiagnosed Myopathy in Children - Routine elective pediatric IM or IV use has become LIMITED because of rare but SEVERE hyperkalemic cardiac arrest in occult myopathy (e.g., Duchenne, Becker, other myopathies). - Use extreme caution. Emergency Algorithm - Suspect Complication (e.g., ↑ ETCO2, rigidity, arrhythmia, hyperkalemia) - Stop Drug Exposure / Trigger: Stop SUX and/or volatile anesthetics - Oxygenate / Ventilate: 100% O2 Ensure adequate ventilation - ECG / Electrolytes: Obtain 12-lead ECG Check K+, ABG, Ca2+, CK, etc. - Treat Specific Emergency: Treat hyperkalemia, treat MH, manage arrhythmias, support ACLS Memory Line: The big dangers are K+, MH, and occult myopathy. Act FAST. Delays can be FATAL. Image 5: Absolute / strong contraindications: - Personal or family history of malignant hyperthermia - Known pseudocholinesterase deficiency (butyrylcholinesterase deficiency) - Prior severe reaction / anaphylaxis to succinylcholine - Active hyperkalemia - Conditions with major extrajunctional receptor upregulation (↑ K+ risk): - Major burns after the first 24 h - Denervation injury (e.g., spinal cord injury) - Progressive neuromuscular disease (ALS, MS, muscular dystrophy) - Prolonged immobilization Use with major caution: - Open globe injury - Penetrating eye injury - Increased intracranial pressure risk (avoid large ↑ in ICP) - Severe sepsis / critical illness myopathy - Muscular dystrophy - Renal failure with pre-existing hyperkalemia - Recent stroke or spinal cord injury - Crush injury - Extensive trauma Special populations - key points: Population - Considerations - B

Anesthesia / Drugs2026-05-12 17:15:27

Open note

Isoflurane Anesthetic Properties and Uses

Isoflurane notes about properties, pharmacology, adverse effect, MAC value, with all standard book references. Class / identity: - Volatile halogenated inhalational anesthetic - Fluorinated chlorinated methyl ethyl ether - Nonflammable, colorless liquid - Relatively pungent - Used mainly for maintenance rather than inhalational induction Chemical / physical profile: - Formula: C3H2ClF5O - Molecular weight: ~184.5 g/mol - Blood:gas partition coefficient: ~1.4 - Oil:gas partition coefficient: ~98 - Vapor pressure (20 °C): ~240 mmHg - Boiling point: ~48.5 °C - MAC in healthy adults in O2: ~1.15% (age-dependent) Mechanism snapshot: - Low to intermediate blood:gas solubility → slower onset and slower emergence than sevoflurane/desflurane - Relatively potent because MAC is low Appearance / equipment: - Delivered via a variable-bypass vaporizer on a compatible anesthesia machine - Colorless liquid - Relatively pungent, ethereal (ether-like) odor Induction friendliness: - Pungent odor irritates airway and increases coughing/laryngospasm risk - Mask (inhalational) induction less suitable - Better tolerated for maintenance after IV induction or after airway is secured Quick comparison: - Feature: Sevoflurane, Isoflurane, Desflurane - Pungency / Airway irritation: Mild, Moderate - High (pungent), Very Pungent (high) - Onset / Offset: Fast / Fast, Slower / Slower, Very Fast / Very Fast - Potency (MAC in O2): ~2.0%, ~1.15%, ~6.0% - Blood:Gas Solubility: 0.65-0.69, ~1.4, ~0.42 - Metabolism: ~2-5%, ~0.2%, ~0.02% Caveats preview: - Hypotension from decreased systemic vascular resistance (SVR) and cardiac depression at higher concentrations - Respiratory depression → ↓ minute ventilation - Pungency/airway irritation limits inhalational induction - Malignant hyperthermia trigger - Can generate carbon monoxide (CO) when used with desiccated CO2 absorbents → monitor CO if absorbent is not indicated Key advantages: - Potent (low MAC) - Relatively inexpensive - Excellent maintenance agent; smooth anesthetic depth - Bronchodilator tendency (useful in reactive airways) - Stable metabolism with minimal metabolic burden (~0.2%) At-a-glance facts: - Best use: MAINTENANCE anesthesia - Flavor / smell: Pungent, ethereal - Onset: Slower than sevo/des - Offset: Slower than sevo/des - Metabolism: Minimal ~0.2% (stable) - Elimination: Primarily exhaled unchanged via lungs Image 2: Mechanism of action: - Volatile anesthetic acting at multiple CNS targets. - Potentiates GABA-A receptor-mediated inhibition → ↑ Cl- influx. - Enhances glycine receptor-mediated inhibition. - Opens two-pore K+ channels (e.g., TREK-1, TASK) → K+ efflux → neuronal hyperpolarization. - Reduces excitatory neurotransmission (↓ glutamate release; ↓ NMDA activity). - Immobility largely mediated at spinal cord level. CNS effects: - Produces hypnosis, amnesia, and immobility. - Dose-dependent ↓ CMRO2. - Cerebral vasodilation at higher concentrations may ↑ CBF and ICP, especially with hypercapnia. - EEG shows progressive slowing with deepening anesthesia. - Seizure-like activity is uncommon. Cardiovascular effects: - Dose-dependent ↓ in blood pressure, mainly from ↓ systemic vascular resistance. - Modest myocardial depression. - Heart rate often preserved or slightly increased. - Cardiac rhythm generally stable. - Less sensitizing to catecholamines than halothane. Respiratory effects: - Dose-dependent respiratory depression. - ↓ Tidal volume with compensatory ↑ respiratory rate. - Blunted ventilatory response to CO2 and hypoxia. - Bronchodilator tendency (↓ airway resistance). - Airway irritation → mask induction less comfortable. Skeletal muscle / uterine effects: - Potentiates nondepolarizing neuromuscular blockers (e.g., rocuronium, vecuronium). - Uterine smooth muscle relaxation at higher concentrations. Dose-response clinical pearls: - Low: Hypnosis + - Moderate: Hypnosis ++, Immobility +, Respiratory depression ++ - High: Hypnosis +++, Immobility +++, Respiratory depression +++ High-yield clinical pearls: - Excellent maintenance agent after IV induction. - Watch ventilation and blood pressure. - Do not rely on isoflurane for a pleasant mask induction. - Bronchodilator tendency can be very useful in reactive airways. - Slow onset ≠ slow emergence with low blood:gas solubility. Organ-system summary: CNS: - Hypnosis, amnesia, immobility - ↓ CMRO2 (dose-dependent) - Cerebral vasodilation at high conc. → CBF, ↑ ICP (esp. with ↑ PaCO2) - EEG slowing with depth - Seizure-like activity uncommon CVS: - ↓ SVR → ↓ BP (dose-dependent) - Modest ↓ myocardial contractility - HR preserved or slightly ↑ - Rhythm stable - Less catecholamine sensitization than halothane RESP: - Dose-dependent ↓ in ventilation - ↓ VT with ↑ RR - Blunted response to CO2 & hypoxia - Bronchodilator tendency - Airway irritation → less comfortable mask induction Image 3: Uptake / distribution fundamentals: - FA depends on inspired concentration, alveolar ventilation, blood:gas solubility, and cardiac output. - Higher blood:gas coefficient (~1.4) means slower FA/FI rise than sevoflurane. - Slower equilibration between alveoli, blood, and brain. Induction / emergence: - Slower induction than sevoflurane and desflurane. - Slower emergence than sevoflurane and desflurane. - Still predictable and controllable. - More suited for maintenance than quick inhalational induction. Solubility & key numbers: - Blood:gas solubility: ~1.4 - Oil:gas solubility: ~98 - Vapor pressure: ~240 mmHg at 20°C - MAC (in adults in O2): ~1.15% (age-dependent) Disposition pathway: - Inspired vapor → Alveoli → Blood → Vessel-rich group / brain → Muscle → Fat → Back to alveoli → Eliminated via lungs Metabolism: - Only about 0.2% metabolized hepatically. - Oxidative metabolism by CYP2E1 to trifluoroacetic acid and inorganic fluoride. Elimination: - Majority (>99.8%) eliminated unchanged through the lungs via exhalation. - Only a very small fraction excreted as metabolites in urine. CO absorbent / carbon monoxide note: - With desiccated CO2 absorbents, isoflurane can degrade and generate carbon monoxide (CO). - CO is toxic and can cause serious patient harm. - Modern practice avoids desiccated absorbents and requires vigilance. Clinical interpretation: - Higher blood:gas solubility (~1.4) explains slower on/off. - Low metabolism (~0.2%) means limited metabolic load. - Favorable hemodynamic stability and organ protection. - Best suited for steady maintenance of anesthesia. Image 4: Indications: - Induction and maintenance of general anesthesia. - Especially useful for maintenance. - Can be used in adults and pediatric patients. - Suitable for balanced anesthesia. - Useful where lower cost is desired. Induction techniques: - Inhalational induction generally not preferred because of pungency and airway irritation. - More commonly used after IV induction or once airway is secured. - If inhaled, titrate gradually rather than aggressive mask induction. Maintenance of anesthesia: - Vaporizer and end-tidal concentration titrated to clinical response. - Common vaporizer range: ~0.5–2.5% - End-tidal roughly around 0.8–1.5% depending on age and context. - MAC modifiers: age, opioids, sedatives, N2O, temperature, surgical stimulation. Delivery equipment: - Variable-bypass vaporizer - Circle breathing system with CO2 absorber - Face mask or airway device - End-tidal gas monitor Monitoring: - ECG - Pulse oximetry (SpO2) - Capnography / EtCO2 - Blood pressure - Temperature - End-tidal isoflurane concentration (if available) - BIS / depth assessment Airway and pediatric points: - Pungency makes mask acceptance worse than sevoflurane. - Can provoke coughing or breath-holding. - Less favored before IV access. - After IV induction, it works well for maintenance. Low-flow / fresh-gas-flow notes: - Low-flow anesthesia is feasible with modern systems. - Ensure absorbent is not desiccated. - Monitor inspired and end-tidal agent concentrations. Stepwise safe administration checklist: 1. Preoxygenate. 2. Induce with IV agent or titrate inhaled agent carefully. 3. Titrate isoflurane to effect. 4. Secure airway if needed. 5. Monitor EtCO2 and hemodynamics. Safe use checklist: - Confirm equipment and vaporizer function. - Ensure adequate scavenging. - Monitor oxygenation / ventilation. - Titrate to clinical response. - Be aware of MAC modifiers. - Maintain normothermia. - Document events. At-a-glance clinical pearls: - Economical maintenance agent. - Potent anesthetic with reliable clinical effect. - Bronchodilator tendency (useful in reactive airways). - Slower onset and offset than sevoflurane. - Less suitable for mask induction. - Well-suited for stable maintenance. Image 5: Adverse effects: - Hypotension from reduced SVR - Respiratory depression / hypoventilation - Postoperative nausea and vomiting - Airway irritation (cough, sore throat) - Cough / laryngospasm during inhalation induction - Rare emergence agitation - Possible increase in ICP at high concentrations, especially with hypercapnia Major safety issues: - Malignant hyperthermia trigger in susceptible patients - Carbon monoxide generation with desiccated CO2 absorbents - Minimal metabolism (~0.2%) → trifluoroacetic acid & fluoride; generally limited clinical burden - Modern absorbent practice reduces risk of CO and heat Contraindications / precautions: - Known or suspected malignant hyperthermia susceptibility - Hypersensitivity to volatile anesthetics - Severe hypovolemia / hemodynamic instability - Raised ICP or seizure-prone states → require careful management - Caution in significant coronary disease or where hypotension is poorly tolerated Special populations: - Pediatrics: not ideal for inhalation indu

Anesthesia / Drugs2026-05-12 07:12:55

Open note

Notes on Oxygen Cascade and Hemoglobin Dissociation Curve

Oxygen cascade and oxyhemoglobin dissociation curve notes covering PO₂ values, A–a gradient, P50, curve shifts, oxygen content, delivery, and clinical physiology. Definition: - The oxygen cascade is the progressive fall in partial pressure of O2 (PO2) as oxygen moves from the atmosphere to the mitochondria where it is utilized. Normal PO2 Values at Sea Level: - Atmosphere (dry): 159 mmHg - Humidified inspired air (at trachea): 149 mmHg - Alveolar air (PAO2): 100-104 mmHg - Arterial blood (PaO2): 95-100 mmHg - Tissue interstitium: 40 mmHg - Mitochondrial PO2: 1-5 mmHg Core Formulas: - Inspired oxygen tension: PIO2 = FIO2 x (PB - PH2O) - Alveolar gas equation: PAO2 = FIO2 x (PB - PH2O) - PaCO2 / R Why PO2 Falls at Each Step: - Humidification of inspired air (water vapor adds 47 mmHg) - Mixing with CO2 in alveolus (CO2 takes up space) - A-a difference due to V/Q mismatch + small physiologic shunt + diffusion limitations - Diffusion from capillary blood to tissues - Utilization of O2 by mitochondria (consumption) Determinants of PO2: - FIO2 (fraction of inspired O2) - Barometric pressure (altitude) - Alveolar ventilation (VA) - PaCO2 - Diffusion capacity (membrane thickness, surface area) - Ventilation-perfusion (V/Q) matching - Cardiac output - Hemoglobin concentration - Tissue extraction (mitochondrial demand, metabolic rate) Clinical Relevance: - Low FIO2 / high altitude → ↓PO2 → ↓PAO2 → ↓PaO2 - Hypoventilation (↑PaCO2) → ↓PAO2 → ↓PaO2 - Diffusion limitation (e.g., fibrosis, edema) → ↓PaO2 - V/Q mismatch (asthma, COPD, pneumonia) → ↓PaO2 - Right-to-left shunt → ↓PaO2 (poor response to O2) - Low cardiac output → ↓O2 delivery to tissues Professor Pearl / Exam Tip: - PaO2 reflects DISSOLVED OXYGEN ONLY (≈ 0.3 mL/dL at PaO2 100 mmHg). Oxygen content (CaO2) depends mainly on HEMOGLOBIN and SATURATION. CaO2 ≈ (1.34 x Hb x SaO2) + (0.003 x PaO2) mL/dL Image 2: Alveolar Gas Equation: - On room air at sea level: PAO2 = FiO2 (PB - PH2O) - PaCO2/R - Typical PAO2 ≈ 100 mmHg on room air at sea level A-a Gradient: - A-a gradient = PAO2 - PaO2 - Normal young healthy adult: ≈ 5-15 mmHg - Age-adjusted approximation: ≈ age/4 + 4 - A widened A-a gradient suggests: V/Q mismatch, diffusion limitation, right-to-left shunt Causes of Hypoxemia: Quick Comparison: - Low FiO2: - A-a Gradient: Normal - Response to Supplemental O2: Good - Common Examples: High altitude, high FiO2 need (e.g., inhaled gas mix) - Hypoventilation: - A-a Gradient: Normal or slightly ↑ - Response to Supplemental O2: Good - Common Examples: COPD exacerbation, CNS depression, neuromuscular disease - Diffusion Limitation: - A-a Gradient: ↑ Widened - Response to Supplemental O2: Good - Common Examples: Pulmonary fibrosis, pulmonary edema, interstitial lung disease - V/Q Mismatch: - A-a Gradient: ↑ Widened - Response to Supplemental O2: Good to fair (most cases) - Common Examples: Asthma, COPD, pneumonia, pulmonary embolism - Right-to-Left Shunt: - A-a Gradient: ↑↑ Markedly widened - Response to Supplemental O2: Poor (minimal) - Common Examples: ARDS, atelectasis, intrapulmonary shunt, congenital heart disease Why PaCO2 Influences PAO2 Inversely: - From alveolar gas equation: PAO2 = FiO2 (PB - PH2O) - PaCO2/R - ↑ PaCO2 → subtracts more → ↓ PAO2 - ↓ PaCO2 → subtracts less → ↑ PAO2 - Ventilate to lower PaCO2 → raise PAO2 Response to Oxygen Therapy: - Good response in: Low FiO2 (e.g., altitude), hypoventilation, diffusion limitation, most V/Q mismatch - Poor response in: Large right-to-left shunt (e.g., ARDS, atelectasis) Alveolus-Capillary Unit & Mechanisms: - Alveolus: PAO2 ≈ 100 - Capillary: PaO2 ≈ 95 Professor Pearl: - Do not confuse hypoxemia (low PaO2) with: - Low oxygen content (low CaO2) - Low tissue oxygen delivery (DO2) - They are related, but not the same! Memory Line: - Low PaO2? Think FiO2, ventilation, diffusion, V/Q mismatch, or shunt. Image 3: Definition: - The oxyhemoglobin dissociation curve depicts the relationship between the partial pressure of oxygen (PO2) and the percentage saturation of hemoglobin (SaO2) in blood. Why Sigmoid? - Hemoglobin (Hb) is a tetramer (4 subunits). - O2 binding is cooperative. - Binding of one O2 increases affinity of remaining sites. - Transition from low-affinity T-state → high-affinity R-state. Basic Oxyhemoglobin Dissociation Curve (Normal): - PO2 100 mmHg ≈ SaO2 97-100% (Arterial blood) - PO2 60 mmHg ≈ SaO2 ~90% - PO2 40 mmHg ≈ SaO2 ~75% - PO2 27 mmHg (P50) ≈ SaO2 50% Flat Upper Portion (High PO2: ~60–100 mmHg): - Curve is flat in lungs. - Hb is near fully saturated. - Protects SaO2 from modest drops in PO2. - Ensures stable loading in the alveoli. P50 (Point of 50%): - PO2 at which Hb is 50% saturated. - Normal value: P50 ≈ 26–27 mmHg - ↑ P50 → RIGHT SHIFT (lower affinity, easier O2 release) - ↓ P50 → LEFT SHIFT (higher affinity, harder O2 release) Clinical Importance: - At PO2 ≈ 60 mmHg, SaO2 ≈ 90%. - Classic exam threshold. - Below this, SaO2 falls rapidly with small drops in PO2 (steep part). - Above this, SaO2 is relatively stable on the flat part. Dissolved O2 vs Hb-Bound O2: - DISSOLVED O2: - Form: Physically dissolved in plasma - Capacity: Very low (~0.3 mL O2/dL blood) - Transport: Proportional to PO2 - Function: Immediate availability - Example at PO2 100 mmHg: ~0.3 mL O2/dL - Hb-BOUND O2: - Form: Chemically bound to hemoglobin - Capacity: High (~20 mL O2/dL blood) - Transport: Follows dissociation curve - Function: Bulk transport & delivery - Example at PO2 100 mmHg: ~19–20 mL O2/dL Key Takeaway: - The basic O2-Hb dissociation curve explains how blood loads O2 in the lungs and unloads it in the tissues. - Shape is determined by cooperative binding and T R transition. Memory Line: - Flat in the lungs, steep in the tissues = stable loading, efficient unloading. Image 4: Right Shift (↓ affinity for O2): - Factors: • ↑ H+ / acidosis • ↑ PaCO2 • ↑ Temperature • ↑ 2,3-BPG • Exercise • Anemia • Chronic hypoxemia / high altitude - Effect: • ↓ O2 affinity • ↑ P50 • Easier O2 unloading to tissues Left Shift (↑ affinity for O2): - Factors: • ↓ H+ / alkalosis • ↓ PaCO2 • ↓ Temperature • ↓ 2,3-BPG • Fetal hemoglobin (HbF) • Carbon monoxide (CO) • Methemoglobinemia • Stored blood - Effect: • ↑ O2 affinity • ↓ P50 • Impaired tissue unloading Bohr Effect: - ↑ CO2 - ↑ H+ promotes O2 unloading in tissues Haldane Effect: - Deoxygenated Hb carries more CO2 (and H+). - Oxygenation of Hb in the lungs promotes CO2 release. Special Situations: - Condition: • HbF (fetal Hb) • CO poisoning • Methemoglobinemia - Curve Effect: • Left shift • Left shift • Left shift - Why?: • ↓ 2,3-BPG binding • CO binds Hb tightly • Fe3+ cannot bind O2 Oxyhemoglobin Dissociation Curves: - Normal - Right shift - Left shift Clinical Examples: Right Shift (enhanced unloading): - Fever / sepsis - Exercise - Chronic lung disease / COPD - High altitude - Anemia - Metabolic acidosis Left Shift (impaired unloading): - Hypothermia - Alkalosis (respiratory or metabolic) - Carbon monoxide poisoning - Blood stored > 2-3 weeks - Methemoglobinemia - Sepsis (late phase) can evolve to left shift Memory Line: - "CADET, face Right!" - use for RIGHT SHIFT • C: CO2 (↑ PaCO2) • A: Acid (↑ H+) • D: DPG (↑ 2,3-BPG) • E: Exercise • T: Temperature (↑) Image 5: Core Formula: Arterial Oxygen Content - CaO2 = (1.34 x Hb x SaO2) + (0.003 x PaO2) mL/dL - 1.34 mL O2 carried per gram of Hb when fully saturated - 0.003 mL O2/dL/mmHg = dissolved O2 Content, Delivery & Consumption Core Relationships - Mixed venous content: CvO2 = (1.34 x Hb x SvO2) + (0.003 x PvO2) - Oxygen delivery (DO2): DO2 = CO x CaO2 x 10 - Oxygen consumption (VO2): VO2 = CO x (CaO2 - CvO2) x 10 - O2 extraction ratio (O2ER): O2ER = VO2 / DO2 Normal Values - CaO2: 19-20 mL/dL - SvO2: 70-75% - PvO2: ~ 40 mmHg - DO2: 900-1100 mL/min - VO2: 200-250 mL/min - O2 Extraction Ratio (O2ER): ~ 25% Comparing Disorders: Same PaO2 Does Not Mean Same CaO2 or Delivery - Parameter: PaO2 (mmHg), Normal: 80-100 - Parameter: SaO2 (%), Normal: 95-100 - Parameter: CaO2 (mL/dL), Normal: 19-20 - Parameter: Tissue O2 Delivery (DO2), Normal: 900-1100 - Anemia: PaO2 Normal, SaO2 Normal, CaO2 ↓ (due to low Hb), Tissue O2 Delivery ↓ - Hypoxemia: PaO2 ↓, SaO2 ↓, CaO2 ↓ (due to low SaO2), Tissue O2 Delivery ↓ - Carbon Monoxide Poisoning: PaO2 Normal or slightly ↓, SaO2 Normal or slightly ↓ (pulse oximetry may be falsely normal), CaO2 ↓ (Hb occupied by CO), Tissue O2 Delivery ↓ Fick Principle / Tissue Extraction - Tissues extract O2 from blood according to demand - VO2 = CO x (CaO2 - CvO2) x 10 - If DO2 falls → tissues extract more (↑ O2ER) to maintain VO2 - until maxed out - If DO2 falls below critical threshold → VO2 becomes supply dependent Why PaO2 Can Be Normal but Delivery Is Impaired - PaO2 reflects dissolved O2 only - Most O2 is carried by hemoglobin - Anemia → less Hb → less CaO2 even if PaO2 is normal - CO poisoning → Hb is occupied by CO → less O2-carrying capacity even if PaO2 is normal - Therefore, tissues may be under-perfused with O2 despite normal PaO2 Clinical Pearls - Transfusion (↑ Hb) raises CaO2 substantially because it increases the major term (1.34 x Hb x SaO2) - RBCs = more payload capacity - Supplemental O2 raises dissolved O2 (0.003 x PaO2 term). This effect is small unless PaO2 is already low - O2 = helps when hypoxemia is present Visual Formula Map - ↑ Hb or SaO2 → ↑ CaO2 - ↑ PaO2 → slight ↑ in CaO2 (only dissolved O2) - ↑ CaO2 → ↑ DO2 = CO x CaO2 x 10 - ↑ VO2 = CO x (CaO2 - CvO2) x 10 - TISSUE RECEIVES O2 Image 6: High Altitude: - PB ↓ → PIO2 ↓ →

Anesthesia / Physiology / Respiratory2026-05-11 10:27:59

Open note

Ozempic (Semaglutide) for Obesity and Type 2 Diabetes

High-yield Ozempic semaglutide notes for weight loss: GLP-1 mechanism, dosing, Wegovy comparison, STEP trials, side effects, warnings, and clinical pearls.

Medicine / Drugs2026-05-10 15:54:26

Open note

Sevoflurane handwritten notes

sevoflurane class, mechanism of action, mac value, pharmacology, adverse effect in handwritten notes.

Anesthesia / Drugs2026-05-09 03:37:00

Open note

Midazolam

Handwritten notes about midazolam. Pharmcology, pharmacodynamics, pharmacokinetics, exam ready notes Image 1: Class / identity: - Short-acting benzodiazepine - Imidazobenzodiazepine - Sedative-hypnotic - Anxiolytic - Amnestic - Anticonvulsant - NO analgesia Unique chemistry / formulation: - Imidazole ring - Water-soluble in acidic formulation (ring open) - Becomes highly lipid-soluble at physiologic pH (ring closes) → Rapid CNS entry and little venous irritation compared with diazepam. Key anesthetic profile: - Rapid onset (IV) - Short duration after single bolus - Reliable anterograde amnesia - Good anxiolysis - Synergistic with opioids and other sedatives Comparison snapshot: - Onset (IV): Fast - Duration: Short - Formulation: Water-soluble - Venous irritation: Low (less thrombophlebitis) - Common routes: IV, Oral, IM, Intranasal High-yield overview pearls: - Excellent for premedication and procedural sedation - Useful as an induction adjunct - Can be used for continuous ICU sedation - Slower recovery with repeated doses or infusion - Keep an eye on cumulative effects in the elderly or critically ill. Image 2: Mechanism of action: - Positive allosteric modulator at GABA_A receptor - Increases frequency of chloride (Cl-) channel opening in the presence of GABA - More Cl- influx - Hyperpolarization - Neuronal inhibition CNS effects: - Sedation - Hypnosis - Anxiolysis - Anterograde amnesia - Anticonvulsant effect - Muscle relaxation - Decreases CMRO2, CBF, and ICP modestly → CPP usually preserved in many settings - EEG slows - No analgesia Respiratory effects: - Dose-dependent respiratory depression - Decreased ventilatory response to CO2 - Apnea possible after rapid IV bolus - Upper airway obstruction risk (especially in sedated/recumbent patients) - Effects are much greater with opioids, alcohol, propofol, or other sedatives Cardiovascular effects: - Mild-to-moderate decrease in SVR and BP - Small fall in cardiac output - Usually modest hemodynamic change in healthy patients - More hypotension in hypovolemia, elderly, or when combined with opioids/other anesthetics Other physiologic pearls: - Minimal histamine release - Little effect on neuromuscular transmission - May reduce recall strongly (anterograde amnesia) - Paradoxical agitation can rarely occur Image 3: Routes / absorption: - IV: 100% bioavailability, direct to circulation - IM: Reliable absorption, bioavailability ~90%+ - Oral: Incomplete bioavailability (~30–50%) due to first-pass metabolism - Intranasal: Useful in pediatrics and seizures - Buccal: Bypasses first-pass metabolism; alternative when IV not available Onset and duration: - IV (small bolus): Onset ~1–2 min, peak effect ~3–5 min, clinical duration ~20–30 min after small IV bolus - IM: Onset ~10–20 min - Oral: Onset ~15–30 min Distribution: - Highly lipophilic at physiologic pH - Rapid brain uptake - High protein binding (~95%) - Volume of distribution (Vd) increases in obesity Metabolism / elimination: - Metabolized by CYP3A4 to 1-hydroxymidazolam (active but weaker) - Elimination half-life (t½): ~1.5–3 hours in healthy adults - Glucuronidation (UGT enzymes) and renal excretion (urine) Context and special PK issues: - Effect is prolonged with repeated doses or infusions - Context-sensitive recovery increases as infusion duration increases - Special considerations: elderly, hepatic impairment, congestive heart failure, obesity, renal failure (metabolite accumulation) Image 4: Premedication: anxiolysis and amnesia before anesthesia - Adults (typical): - Oral: 7.5-15 mg - IM: ~0.07-0.1 mg/kg - IV: small titrated doses 0.5-2 mg - Pediatrics: - Oral: ~0.25-0.5 mg/kg (commonly max ~20 mg) - Intranasal: ~0.2-0.3 mg/kg Procedural sedation / monitored anesthesia care - IV titration in small increments - Often total 1-5 mg in healthy adults - Usually combined with analgesic (e.g., fentanyl) - Caution: respiratory depression Induction / co-induction - Induction dose if used alone: ~0.1-0.3 mg/kg IV - Lower doses as co-induction adjunct to reduce requirements of propofol or other anesthetics ICU / prolonged sedation - Intermittent bolus or infusion - Example: ~0.02-0.1 mg/kg/hr - Recovery may be delayed after long infusions Other important uses - Status epilepticus / seizure control (especially IV/IM/ intranasal) - Anxiolysis before regional anesthesia - Sedation in mechanically ventilated patients - Adjunct to reduce recall (amnesia) Always titrate to effect; reduce dose in elderly/frail patients. MEMORY LINE: Midazolam is most often used for premedication, procedural sedation, induction adjunct, and ICU sedation - always titrate carefully. Primary source: Stoelting's Pharmacology & Physiology in Anesthetic Practice. Image 5: Common adverse effects: - Excessive sedation - Drowsiness - Psychomotor impairment - Dizziness - Ataxia - Confusion - Postoperative delayed recovery Respiratory hazards: - Hypoventilation - Apnea - Airway obstruction - Especially after IV bolus or with opioids - Higher risk in OSA, COPD, obesity, elderly, and frail patients. Hemodynamic adverse effects: - Hypotension, especially in hypovolemia or with other anesthetics - Occasional bradycardia Neuropsychiatric issues: - Paradoxical agitation / disinhibition - Delirium in susceptible patients - Rare involuntary movements - Tolerance and withdrawal with prolonged ICU use Monitoring / practical safety: - Titrate slowly - Allow time between doses - Continuous pulse oximetry during sedation - Capnography when appropriate - Be prepared for airway support - Resuscitation drugs/equipment available Image 6: Major drug interactions: - CYP3A4 inhibitors → ↑ midazolam levels / ↑ effect - Erythromycin / clarithromycin - Azole antifungals (ketoconazole, itraconazole, voriconazole) - Protease inhibitors (e.g., ritonavir) - Diltiazem / verapamil - Grapefruit (juice) - CYP3A4 inducers → ↓ midazolam levels / ↓ effect - Rifampin, carbamazepine, phenytoin Marked synergistic respiratory depression with CNS depressants: - Opioids (e.g., fentanyl, morphine) - Propofol - Alcohol - Other sedatives / hypnotics (e.g., barbiturates, Z-drugs) Elderly / frail: - Increased sensitivity to midazolam - Smaller central volume of distribution - Reduced clearance → Start with much lower doses and titrate slowly Organ dysfunction: - Hepatic disease, heart failure, shock: Reduced clearance → prolonged effect - Renal failure: Active metabolite conjugates may accumulate, Prolonged sedation possible Special populations: - Obesity / OSA / pulmonary disease: Dose carefully, Higher risk of airway obstruction and delayed recovery - Pregnancy / neonates: Use only when clearly indicated, Neonatal respiratory depression and hypotonia can occur Contraindications / strong cautions: - Hypersensitivity to benzodiazepines - Severe respiratory compromise without ventilatory support - Acute narrow-angle glaucoma (classic benzodiazepine caution) - Myasthenia gravis / severe sleep apnea → use with caution - Midazolam alone DOES NOT provide analgesia for painful procedures. Image 7: Flumazenil Reversal: - Competitive benzodiazepine antagonist - Adult IV reversal commonly 0.2 mg increments titrated to effect (up to ~1 mg in many routine settings; higher cumulative doses possible) - Onset: rapid (1–2 min) - Duration shorter than some benzodiazepine effects → resedation can occur - CAUTION: May precipitate seizures in benzodiazepine-dependent patients or in mixed overdose with pro-convulsant drugs Midazolam vs Propofol: - Midazolam: Stronger amnesia, Slower recovery, No analgesia, Less hypotension in many patients, Reversible with flumazenil - Propofol: Less amnesia, Faster recovery, No analgesia, More hypotension, No reversal agent Midazolam vs Diazepam: - Midazolam: Water-soluble, Less venous irritation, Faster onset, Shorter recovery, More suitable for titrated IV sedation - Diazepam: Lipid-soluble, More venous irritation, Slower onset, Longer recovery, Less ideal for titrated IV sedation Professor Pearls / Viva Points: - No analgesia - Produces pronounced anterograde amnesia - Imidazole ring explains water solubility in vial - Metabolized in liver by CYP3A4 - Active metabolite (1-OH midazolam) can accumulate in renal failure - Combination with opioids greatly increases risk of apnea and respiratory depression - Flumazenil reverses, but watch for resedation Mini Algorithm / Checklist Before Giving Midazolam: 1. Assess airway & OSA risk - History - Airway exam - OSA / BMI 2. Consider age & comorbidities - Elderly - Hepatic / renal impairment - Cardiac disease 3. Check concurrent opioids / CNS depressants - Opioids - Alcohol / benzos - Other sedatives 4. Ensure IV access & monitoring - Pulse oximetry - BP / ECG - Capnography (if deep sedation) 5. Titrate slowly - Small IV doses - Titrate to effect - Pause and reassess 6. Observe recovery & discharge safety - Stable vitals - Alert / oriented - Escort / instructions

Anesthesia / Drugs2026-05-09 01:56:39

Open note

Hantavirus Notes: HCPS vs HFRS, Symptoms, Diagnosis & Treatment

High-yield Hantavirus medical notes covering HCPS/HPS, HFRS, rodent transmission, symptoms, diagnosis, treatment, prevention, and exam pearls for medical students and doctors.

Medicine / Infectious Diseases2026-05-08 19:25:23

Open note

Medicine Study Notes

Anesthesia Calculators

Calculator List

Intra-op Fluid Management

Airway Calculator

Infusion Rate Calculator

Anesthesia Drug Dose

LAST Toxicity Limits

ASA Physical Status

Aldrete Score

Apfel PONV Score

STOP-BANG Score

Modified Mallampati Classification

Maintenance Fluid Calculator

IV Drip Rate Calculator

Tidal Volume / PBW Calculator

RASS Sedation Scale

Revised Cardiac Risk Index

Caprini VTE Risk Score

Intra-op Fluid Management

Formula and calculation method

Airway Calculator

Formula and calculation method

Infusion Rate Calculator

Formula and calculation method

Anesthesia Drug Dose

Formula and calculation method

LAST Toxicity Limits

Formula and calculation method

ASA Physical Status

Formula and calculation method

Aldrete Score

Formula and calculation method

Apfel PONV Score

Formula and calculation method

STOP-BANG Score

Formula and calculation method

Modified Mallampati Classification

Formula and calculation method

Maintenance Fluid Calculator

Formula and calculation method

IV Drip Rate Calculator

Formula and calculation method

Tidal Volume / PBW Calculator

Formula and calculation method

RASS Sedation Scale

Formula and calculation method

Revised Cardiac Risk Index

Formula and calculation method

Caprini VTE Risk Score

Formula and calculation method

Contact Us

How to Reach Us

DM to:

Contact Methods